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Summary 
Regulated exocytosis, as exampled in insulin secretion stimulated by glucose and other 
secretagogues from pancreatic islet β cells, is regulated by multiple signaling 
pathways. In this study, the possible roles of two proteins (Rac1 and syncollin) in 
regulated exocytosis were investigated by using insulin-secreting INS-1 cells as a 
model system. 
Rac1 is a member of the Rho family GTPases regulating cytoskeletal organization, and 
recent evidences implicated Rac1 in the exocytotic process. Herein, the translocation 
of Rac1 from the cytosol to the membrane fraction (including the plasmalemma), an 
indication of Rac1 activation, was found in insulin-secreting INS cells upon the 
exposure to the stimulatory glucose concentrations. Time course study indicated that 
such an effect was demonstrable only after 15 min stimulation with glucose. 
Furthermore, glucose stimulation increased Rac1 GTPase activity. The expression of a 
dominant inhibitory Rac1 mutant (N17Rac1) abolished glucose-induced translocation 
of Rac1, and significantly inhibited the insulin secretion stimulated by glucose and 
forskolin. This inhibitory effect on glucose-stimulated insulin secretion was more 
obvious in the late phase of secretion. However, N17Rac1 expression did not 
significantly affect insulin secretion induced by high K+. INS-1 cells expressing 
N17Rac1 also displayed significant morphological changes and disappearance of F-
actin structures. The expression of wild type Rac1 or a constitutively active Rac1 
mutant (V12Rac1) did not significantly affect either the stimulated insulin secretion or 
the basal release, suggesting that Rac1 activation is essential, but not sufficient, for 
evoking secretory process. These data have demonstrated, for the first time, that Rac1 
may be involved in glucose and forskolin stimulated insulin secretion, possibly at the 
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level of recruitment of secretory granules through regulating actin cytoskeletal 
network reorganization. 
This study also investigated the role of syncollin, a secretory granule associated 
protein with possible capablility of interaction with syntaxin in a Ca2+-dependent 
manner in vitro, in regulated exocytosis in the intact cell in vivo. To this aim, syncollin 
and a truncated form of the protein (without N-terminal hydrophobic domain) were 
stably transfected in insulin-secreting INS-1 cells that appear not to express the protein 
per se. Both the subcellular fractionation analysis and the double immunofluorescence 
staining revealed that the transfection of syncollin produced strong signals in the 
insulin secretory granules, whereas the product from transfecting with the truncated 
syncollin was predominantly associated with the Golgi apparatus and partly with ER. 
Importantly, the insulin secretion stimulated by glucose and other secretagogues was 
impaired in the cells expressing syncollin, but not affected by expressing the truncated 
syncollin. These findings have indicated that syncollin can be sorted into insulin 
secretory granules specifically and impair regulated insulin secretion. The N-terminal 
hydrophobic domain of syncollin is essential to accomplish these processes.   
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Abbreviations 
AMP  Adenosine 3’- monophosphate 
ATP  adenosine triphosphate 
cAMP  Adenosine 3',5'-cyclic monophosphate, cyclic AMP 
DEPC  diethyl pyrocarbonate 
DNA  deoxyribonucleotide acid 
DTT  dithiothreitol 
EDTA  ethylene diamine tetra acetic acid 
EGTA  ethylene glycol-bis [-aminoethyl ether]-N, N, N’N’-tetraacetic acid 
FITC  fluorescein-5-isothiocyanate 
GAP  GTPase-activating proteins 
GDI  guanine nucleotide dissociation inhibitors 
GEF  guanine nucleotide exchange factors 
GDP  guanosine diphosphate 
GTP  guanosine triphosphate 
HEPS  N-2-Hydroxyethylpiperazine-N'-2-Ethanesulfonic Acid 
HRP  horseradish peroxidase 
IDDM  insulin-dependent diabetes mellitus 
MTS  3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4- 
  sulfophenyl)-2H-tetrazolium  
NIDDM  noninsulin-dependent diabetes mellitus 
NSF  N-ethylmaleimide-sensitive fusion protein 
PAGE  polyacrylamide gel electrophoresis 
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PAK  p21-activated kinase 
PBS  phosphate-buffered saline 
PKA  cAMP dependent protein kinase 
PIP  phosphatidylinositol phosphate 
PIP2  phosphatidylinositol-4,5-diphosphate 
PMSF  phenyl methyl sulforyl fluoride 
RNA  ribonucleotide acid 
SDS  sodium dodecyl sulphate 
SNAP  soluble NSF attachment protein 
SNARE soluble NSF receptors, soluble NSF attachment protein receptors 
TBS  Tris-buffered saline  
TEMED tetramethylethylenediamine 
TRITC  tetramethyl rhodamine isothiocyanate  
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Chapter 1      
Introduction 
1.1 Regulation of secretory granule exocytosis  
The traffic of secretory vesicles to the plasma membrane in eukaryotic cells is essential 
for normal cellular function. It forms the basis of intercellular communication in 
multicellular organisms through the release of a wide array of extracellularly acting 
molecules. All eukaryotic cells continuously insert vesicles into the plasma membrane 
by exocytosis, usually simultaneously secreting materials into the extracellular space 
(Palade, 1975). In addition, some cells perform more specialized forms of exocytosis 
that are used to release materials in a highly regulated manner. The fundamental 
pathway and the basic machinery for regulated and constitutive exocytosis are similar, 
but their regulation differs (Burgess and Kelly, 1987). The major difference between 
the two types of exocytosis is that, in the regulated exocytosis, secretory materials are 
stably accumulated in secretory vesicles or granules as storage sites, whereas in 
constitutive exocytosis, secretory materials are continuously released. Thus, in the 
regulated pathway, exocytosis of secretory vesicles is arrested at a late step and only 
proceeds when the appropriate stimulus is applied. A typical example is the pancreatic 
β-cell, which is loaded with innumerable granules containing insulin, ready to be 
stimulated for exocytosis when blood glucose levels rise. The regulated exocytosis has 
been extensively studied in synapses where it is the mechanism by which 
neurotransmitters are very rapidly released in a controlled manner from synaptic 
vesicles to mediate neurotransmission (Kelly, 1993; Zucker, 1996). A wide range of 
non-neuronal cell types contain regulated secretory vesicles identified as dense-core 
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granules or secretory granules, the contents of which serve a diverse range of 
physiological functions. These include the cells specialized to secrete large amounts of 
secretory products, for example, neuroendocrine, endocrine, and exocrine cells. 
A large number of the proteins involved in the control of synaptic vesicle exocytosis 
has been identified (Lin and Scheller, 2000; Sollner et al., 1993; Sudhof, 1995). The 
interactions between these proteins and the way in which a Ca2+ signal leads to 
synaptic vesicle exocytosis are known in outline (Lin and Scheller, 2000). Similar 
molecular events appear to underlie secretory granule exocytosis (Brumell et al., 1995; 
Guo et al., 1998; Lang, 1999; Pinton et al., 2002)  
The secretory granules and their regulated exocytosis have been most extensively 
studied in a few cell types chosen either as the model systems due to certain 
experimental advantages, or by their crucial physiological/pathophysiological interest. 
The pathway followed by secretory proteins through the cell was delineated in classical 
studies by George Palade in pancreatic exocrine cells (Palade, 1975). The pancreatic β-
cell (Lang, 1999; Wollheim et al., 1987) is studied due to the importance of insulin 
secretion, and its dysfunction in both type 1 and type 2 diabetes mellitus. 
Haematopoietic cells, including mast cells, platelets and neutrophils (Brown et al., 
1998; Chatah and Abrams, 2001; Rosales and Ernst, 2000), and adrenal chromaffin 
cells (Gandia et al., 1997; Vitale et al., 2000), are also widely used models for 
investigation of exocytosis.  
1.2 Insulin secretion as a model system for studying regulated exocytosis  
The pancreatic islet β-cell is a typical example of peptide-secreting endocrine cells. 
Proinsulin, the precursor of insulin, is synthesized in the endoplasmic reticulum and 
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undergoes a series of maturation steps, starting in the Golgi apparatus. The product is 
then packaged into secretory granules that gradually acidify, allowing further 
processing into insulin (Hutton, 1994). These granules are found throughout the 
cytosol and eventually translocated to the plasma membrane. The ultimate fusion of 
the granule with the plasma membrane is triggered by Ca2+ and controlled by a 
complex network of protein-protein and protein-lipid interactions that are similar in 
other cellular membrane fusion events, and largely conserved in eukaryotic cells.  
Many of the proteins involved in the regulation of neurotransmitter release have also 
been identified in the pancreatic β-cell and demonstrated to participate in insulin 
secretion (Lang, 1999)  
Insulin secretion from pancreatic β-cells is a complex and precisely regulated process, 
constituting an important part in the regulation of body homeostasis. The secretory 
response in pancreatic β cells is coupled with the stimulation of glucose and other 
metabolizable nutrients together with hormones and neurotransmitters. Glucose and 
nutrients regulate insulin secretion by depolarizing the β-cell membrane resulting in 
Ca2+ influx through voltage-dependent channels, whereas hormones and 
neurotransmitters modulate this process by action on heterotrimeric G-proteins that 
transduce multiple second messengers.  
Pancreatic β-cell is critical for nutrient metabolism since it is the main source to 
produce anabolic hormone. Therefore, the dysfunctional insulin secretion is a crucial 
factor in the development of diabetes, a severe metabolic syndrome characterized with 
hyperglycemia. Study of the exocytosis using the insulin secretion model will benefit 
to the understanding of both the fundamental mechanism of regulated exocytosis and 
the pathogenesis of diabetes development. 
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However, the use of primary β-cells in biochemical and molecular biology research is 
limited by the difficulty in isolating enough pancreatic endocrine tissue required for 
many basic studies on the mechanism of insulin secretion. Thus several insulin-
secreting cell lines have been established, these cells retain the ability to secrete insulin 
in regulated manner, although their reactions to different secretagogues may vary from 
primary β-cells. The most widely used insulin-secreting cell lines are RIN (Gazdar et 
al., 1980), HIT-T15 (Santerre et al., 1981), βTC (Efrat et al., 1988), MIN6 (Miyazaki 
et al., 1990) and INS-1 cells (Asfari et al., 1992). These cells contain mainly insulin 
and in some may also have small amount of glucagon and somatostatin. RIN cells are 
not responsive to glucose stimulation. HIT-T15 and βTC cells secrete insulin in 
response to glucose but their dose-response curve is markedly shifted to the left. INS-1 
and MIN6 retain the property of insulin secretion in response to the physiological 
ranges of glucose concentrations. In the present study,  INS-1 cells were used as a 
model for insulin secretion. 
INS-1 cells have been established from cells isolated from an X-ray-induced 
transplantable rat insulinoma (Asfari et al., 1992). Growth of these cells is dependent 
on the existence of the reducing agent 2-mercaptoethanol. The content of insulin is 
about 8 micrograms/106 cells, corresponding to 20% of the content in native β-cells. 
These cells synthesize both proinsulin I and II and display conversion rates of the two 
precursor hormones similar to those observed in rat islets although proinsulin synthesis 
is not stimulated by glucose. Under perifusion conditions, 10 mM glucose enhances 
secretion by 2.2-fold. In the presence of forskolin and 3-isobutyl-1-methylxanthine 
that elevate cellular cAMP levels, the increase of glucose concentration from 2.8 to 20 
mM causes a 4-fold enhancement of the rate of secretion. Glucose also depolarizes 
INS-1 cells in a dose-dependent manner and raises the concentration of cytosolic free 
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Ca2+ ([Ca2+]i) between 0.5-16.7 mM (Ullrich et al., 1996). In addition, INS-1 cells 
have remained stable and retain a high degree of differentiation, making them a 
suitable model for studying various aspects of β-cell function. 
1.3 Insulin secretion in normal and diabetic subjects 
Insulin is an essential hormone for the maintenance of homeostasis of the blood 
glucose levels. The in vivo dose-response curve that describes the relationship between 
insulin secretion and glucose levels in humans is sigmoidal in shape. However, the 
dose-response relationship between glucose and insulin secretion is near linear when 
glucose levels are below 15 mM. In addition, the sensitivity of β-cells to glucose is 
altered by the prior exposure to glucose. Exogenous infusion of glucose increases 
secretion rates of β-cell upon same glucose stimulus, while a 72-hour fast causes a 
reduction of sensitivity of β-cells to glucose resulting in reduced insulin secretion. 
Low-dose glucose infusion, fasting, and refeeding can modify β-cells’ response to 
glucose stimulation in normal weight, non-diabetic subjects (Byrne et al., 1995). The 
mechanism whereby changes in β-cell sensitivity to glucose are mediated has been 
studied in vitro. It has been suggested that this may involve the regulation of the 
enzyme glucokinase that functions as a glucose sensor, since the changes of β-cell 
sensitivity to glucose are correlated with alterations in the levels and activity of 
glucokinase (Liang et al., 1992). The activity of glucokinase in the islets plays a 
crucial role in glucose-induced insulin secretion, since the increased expression of the 
hexokinase also enhances the sensitivity of β-cell to glucose (Becker et al., 1996). 
Diabetes mellitus is characterized by chronic hyperglycemia, which results from a 
failure of the body to release adequate amounts of the blood glucose-lowering 
hormone insulin, from the inability of the target organs to respond to insulin for 
 Chapter 1 Introduction  
 - 10 - 
increasing uptake of glucose, or a combination of both. Diabetes is classified into two 
main groups: “insulin-dependent diabetes mellitus” (IDDM or type 1) and “noninsulin-
dependent diabetes mellitus” (NIDDM or type 2). Type 1 diabetes is caused by 
autoimmune destruction of β-cells in pancreatic islets, which results in deficiency of 
insulin secretion. Thus these patients require insulin injection or pancreas/islets 
transplantation for survival. Type 2 diabetes is characterized by the inefficacy in 
utilization of insulin in insulin-targeted tissues while blood insulin levels usually are 
not low. Additionally, already at early stages of disease the normal pattern of insulin 
release is disturbed so that the rapid but transient initial peak of secretion in response 
to a glucose challenge (first phase) is absent, while a slow but sustained insulin release 
remains (second phase).  
About 90% diabetic patients are type 2 diabetes. Multiple factors contribute to the 
development of type 2 diabetes, which displays heterogeneous metabolic disorders and 
clinical syndromes. Both secretory defects and insulin resistance occur by the time 
when glucose intolerance develops. The insulin secretory abnormalities in type 2 
diabetes include the rise of fasting insulin levels and the loss of the first phase of 
insulin secretion in response to an intravenous glucose infusion. The second phase 
insulin release is also delayed and attenuated. In contrast to the reduced sensitivity to 
glucose, insulin secretory responses to the non-glucose secretagogues (such as 
arginine) remain relatively intact, although the potentiated glucose effect by glucagon, 
secretin, and isoproterenol is impaired. Because of the secretory defects associated 
with diabetes, it is important to understand the molecular mechanisms underlying 
insulin release under both normal and pathological state. 
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1.4 Biogenesis of insulin secretory granules 
Biologically active human insulin consists of two polypeptide chains, the A chain (21 
amino acids) and B chain (30 amino acids), joined by two interchain disulfide bonds. 
There is also an intrachain disulfide bond in the A chain. Insulin structure is highly 
conserved in higher vertebrate evolution (Steiner et al., 1985). Several regions, 
including the position of cysteins that form the disulfide bond, the N- and C-terminal 
regions of A chain and the hydrophobic residues at the C-terminal of B chain, are 
highly conserved in evolution. 
Insulin is initially synthesized as preproinsulin, the precursor of insulin, which has a 24 
amino acid signal peptide in the N terminal and a 31 amino acids connecting peptide 
(C-peptide) between the A chain and the B chain. The signal peptide’s function is to 
facilitate preproinsulin into the rough endoplasmic reticulum (RER). While in the 
lumen of RER, the signal peptide is removed, and preproinsulin is converted to 
proinsulin (Pfeffer and Rothman, 1987). Translocation of a newly synthesized 
proinsulin into the RER lumen makes its entrance into the β cell’s secretory pathway. 
The rate of proinsulin biosynthesis is controlled by many factors, including nutrients, 
neurotransmitters, hormones, and protein kinase activities (Campbell et al., 1982). 
Glucose is the most important and potent physiological regulator of proinsulin 
biosynthesis (Ashcroft et al., 1978). In RER, proinsulin undergoes a folding process so 
that the disulfide linkage between the A and the B chain of insulin are aligned. The C-
peptide is believed to aid correct structure alignment in the process (Chen et al., 2002). 
Correctly folded proinsulin is then delivered to Golgi apparatus from RER in transport 
vesicles.  
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After having been transported to the Golgi apparatus, proinsulin accumulates in 
clathrin-coated regions of the trans–Golgi network (TNG), where the secretory 
granules are originated. The proinsulin is sorted and targeted to the regulated secretory 
pathway. This is a highly efficient process, with more than 99% of the newly 
synthesized proinsulin delivered to the secretory granule compartment (Rhodes and 
Halban, 1987). The proproteins destined for dense-core granules of the regulated 
pathway must present features allowing them to be sorted at the level of the TGN. For 
proinsulin, it has been shown that residues 16 (Leu) and 17 (Glu) of the A-chain and 
13 (Glu) and 17 (Leu) of the B-chain serve as ‘sorting domains’ for correctly sorting to 
secretory granules. The mutants of these residues result in diversion of proinsulin to 
the constitutive pathway (Orci et al., 1981). 
In brief, the maturation of secretory granules includes proinsulin conversion, 
progressive intragranule acidification, loss of clathrin coat, and formation of 
hexameric insulin crystal. Matured secretory granules containing insulin and C-peptide 
are kept in intracellular storage pools, waiting for signals to trigger their transport to 
the plasma membrane for exocytosis.  
1.5 Physiological regulation of insulin secretion 
Glucose is the primary physiological stimulus for insulin secretion and the secretory 
responsiveness of β-cells is set optimally for maintenance of blood glucose in the 
range of 5-7 mM. Glucose enters β-cells via the high Km transporter GLUT-2. The 
generation of metabolic coupling factors through glucose metabolism in β-cells is the 
central pathway of inducing insulin secretion. The probable reason for the exquisite 
sensitivity of β-cells to glucose lies in the presence of the low affinity glucokinase; its 
Km for glucose is set at 8 mM which precisely regulates glucose phosphorylation, the 
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first step of glucose metabolism, in the concentration ranges at which secretion is 
stimulated.  
Apart from glucose, a number of other nutrients including other hexoses, pentoses 
(such as mannose), and trioses such as glyceraldehyde, are also capable of stimulating 
insulin secretion. They share in common a capability to enter and be metabolized by 
the β-cells (Rasmussen et al., 1990). Amino acids and some species of fatty acids, such 
as leucine, glutamine and 2-ketoisocaproic acid, can also induce insulin release. Their 
metabolism in β-cells, similar to glucose metabolism, may generate ATP which in turn 
closes ATP-sensitive potassium (KATP) channels, leading to the membrane 
depolarization and Ca2+ entry (McClenaghan et al., 1996). Basic amino acids such as 
arginine are able to directly depolarize β-cells, thereby facilitating Ca2+ entry (Sener et 
al., 1989). 
While glucose is the major physiological insulin secretagogue, a wide variety of 
hormones and neurotransmitters also affect insulin secretion through endocrine, 
paracrine and neural mechanisms. Glucagon, glucagon-like peptide-1 (GLP-1), and 
Gastric inhibitory peptide potentiate insulin secretion by binding to their receptors in 
the β-cell membrane which activate adenylate cyclase via interaction with a 
stimulatory G-protein (Gs). This in turn promotes synthesis of cyclic AMP that is a 
positive modulator of insulin secretion (Holst et al., 1987; Lu et al., 1993). 
Acetylcholine and cholecystokinin potentiate insulin secretion through increasing 
[Ca2+]i and activating protein kinase C (PKC) following G-protein mediated 
stimulation of phospholipase C (PLC) (Bertrand et al., 1986; Simonsson et al., 1996). 
Catecholamines (such as epinephrine and norepinephrine) inhibit insulin secretion in 
response to various stimuli by inhibiting production of cyclic AMP, reducing Ca2+ 
entry or directly interfering with exocytosis (Persaud et al., 1989). Other agents, e.g. 
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somatostatin (Malm et al., 1991), pancreastatin (Efendic et al., 1987) and galanin 
(Ahren et al., 1989), also exhibit inhibitory effects on insulin secretion in similar 
manners.  
1.6 Intracellular signal transduction for insulin release 
Secretagogues including glucose and other fuels, hormones and neurotransmitters, 
stimulate insulin secretion by producing intracellular signals in β-cells. An increase of 
[Ca2+]i is the most important signal for triggering insulin secretion. Glucose 
metabolism results in closure of KATP channels, leading to membrane depolarization. 
This causes the opening of voltage-gated Ca2+ channels (Dukes and Philipson, 1996). 
Calcium entering into β-cells may activate phospholipase A2 and PLC (Lang et al., 
1994; Ramanadham et al., 1996), generating arachidonic acid and inositol 1,4,5-
trisphosphate (IP3), both of which have been shown to mobilize Ca2+ from pools 
located in ER and thus further elevate [Ca2+]i (Rustenbeck and Lenzen, 1992). 
Insulin secretion from β-cells is under positive or negative modulation of 
neurotransmitters and hormones. In contrast to the action of glucose, these agents act 
through membrane receptors. Signal transduction is mediated by a group of membrane 
associated GTP-binding proteins (G-proteins). Heterotrimeric G-proteins consist of 
three subunits: the α, β, and γ. These proteins are signal transducers that communicate 
signals from many hormones, neurotransmitters, chemokines, as well as autocrine and 
paracrine factors. The extracellular signals are received by members of a large 
superfamily of receptors with seven membrane-spanning domains and G-protein 
activation ensues. Activation of the G-protein is initiated by inducing the exchange of 
GDP for GTP on the α subunit leading to conformational change with a disassociation 
of the heterotrimer into Gα subunit and the Gβγ dimmer. Both the Gα subunit and the 
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Gβγ dimer act on a number of effectors. The activity of heterotrimeric GTPase is 
terminated by the intrinsic GTPase activity of Gα subunit (Mumby, 2000). There are at 
least 20 known Gα, 6 Gβ, and 11 Gγ subunits. On the basis of sequence similarity, the 
Gα subunits have been divided into several families: Gs, Gi/o, Gq/11, G12/13 (Neves et al., 
2002). The Gs activates adenylate cyclase and mediates the response of glucagons and 
vasoactive intestinal peptide (Gomez et al., 2002; Johansen et al., 2001). The Gi 
inhibits cyclase activation and is coupled to somatostatin and α2-adrenergic receptors, 
providing a clue to the mechanism by which these peptides inhibit insulin secretion 
(Ella et al., 1997; Wittpoth et al., 2000). The Gi and Go may also modulate protein 
trafficking from ER to Golgi apparatus, and then to secretory vesicles or granules 
(Vitale et al., 1993; Vitale et al., 1994). The Gq is classically activated by calcium-
mobilizing hormones and stimulates PLC-β to produce two intracellular messengers: 
inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers the release of 
calcium from intracellular stores, while DAG recruits protein kinase C (PKC) to the 
membrane and activates it (Gasa et al., 1999). Gβγ dimer also plays an important role in 
exocytosis, since inactivation of free Gβγ at the level of the plasma membrane 
completely abolishes Ca2+- and GTPγS-evoked insulin release in cloned β cells (Zhang 
et al., 1998). 
Protein phosphorylation is a common way to regulate insulin secretion. The important 
second messengers calcium, cAMP, and diacylglycerol, which are generated from 
glucose metabolism and receptor agonist stimulation, activate Ca2+/calmodulin-
dependent protein kinase II, protein kinase A and protein kinase C, respectively. These 
protein kinases phosphorylate a variety of proteins in β-cells, which participate in the 
cascade of stimulation of insulin secretion (Jones and Persaud, 1998). 
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1.7 Rho family of small GTPases as molecular switches 
The Rho GTPases form a subgroup of the Ras superfamily of 20-30 kD GTP-binding 
proteins that have been shown to regulate a wide spectrum of cellular functions. These 
proteins are ubiquitously expressed from yeast to mammalian cells. Rho was first 
identified in 1985 as a small GTP-binding protein related to Ras (Madaule and Axel, 
1985). This protein is a target of the clostridium botulinum C3 transferase, a bacterial 
coenzyme that induces ADP ribosylation (Williamson et al., 1990). Several other 
members of the Rho family have been identified, including Cdc42 and Rac (Shinjo et 
al., 1990; Shirsat et al., 1990).  
Different mammalian Rho GTPases are at least 40% identical to each other at the 
amino-acid level, whereas they are approximately 25% identical to Ras. To date, only 
Rho, Rac, and Cdc42 have been characterized extensively in the Rho family. In 
mammals, there are three highly homologous isoforms of Rho, known as RhoA, RhoB, 
and RhoC, which are over 85% identical at the amino-acid level. The majority of the 
differences lie within the last 15 amino acids of the carboxy terminus (Ridley, 2000). 
Similarly, Rac1, Rac2, and Rac3 are over 88% identical, and differ primarily within 
the carboxy-terminal 13 amino acids (Haataja et al., 1997). Rac1 is widely expressed 
in different tissues and cell lines, while Rac2 is only expressed in haematopoietic cells 
and Rac3 appears to be expressed selectively in the developing nervous system 
(Haataja et al., 1997; Shirsat et al., 1990). The Cdc42 gene was initially identified in S. 
cereoisiae as a cell cycle mutant defective in budding (Johnson and Pringle, 1990). It 
has two mammalian isoforms with different carboxy terminal sequences (Shinjo et al., 
1990).  
The members of the Rho family have emerged as important players in signal 
transduction processes activated by a variety of both extracellular and intracellular 
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stimulants. These molecules are the major regulators of actin cytoskeleton in 
eukaryotic cells (Hall, 1998). In addition, they are also involved in many other cellular 
responses, including activation of MAPK cascades and regulation of transcription 
factors, secretion, endocytosis, cell polarity, and the cell cycle. Accordingly, they play 
crucial roles in the development and behaviors of multicellular organisms. 
1.8 Regulation of the activity of Rho GTPase 
Rho proteins are active when bound to GTP and inactive when bound to GDP. The 
transition of the two forms is regulated by three groups of proteins (Fig. 1.1). The 
guanine nucleotide exchange factors (GEFs) enhance the exchange of bound GDP for 
GTP, leading to activation of G-proteins. The GTPase-activating proteins (GAPs) 
increase the rate of hydrolysis of bound GTP, resulting in inactivation of G-proteins. 
The guanine nucleotide dissociation inhibitors (GDIs) bind the inactive form of G-



















Fig. 1.1. Schematic diagram for the regulation 
of activity of Rho proteins. It is known that the 
inactive Rho proteins are associated with GDI 
and retained in cytosol. In response to upstream 
stimulating signals, GEFs activate the Rho 
proteins by promoting their binding to GTP and 
releasing GDP. The active G-proteins are then 
translocated from cytosol to the target 
membranes where they interact with their 
effectors that initiate downstream responses. The 
GTPase activity is markedly enhanced by GAP, 
which renders the Rho proteins inactive and 
facilitates their relocation to cytosol where they 
binds to GDI.  
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Over 30 potential GEFs for Rho GTPases have been identified. All possess a 
conserved exchange factor domain, known as the Dbl homology (DH) domain, 
adjacent to a pleckstrin homology (PH) domain (Van Aelst and D'Souza-Schorey, 
1997). The majority of GEFs can activate several Rho GTPases in vitro, although 
some show preference for one or a subgroup of proteins. The active Rho proteins 
would associate with target membranes, where they interact with downstream 
effectors. 
The intrinsic GTPase activity of Rho proteins normally is very low and requires Mg2+ 
(Zhang et al., 2000). Once Rho proteins are activated upon binding GTP, their activity 
is terminated by GTP hydrolysis, yielding GDP binding forms and release of 
phosphate. The GTP hydrolysis rate can be markedly enhanced by GAPs. The GAPs 
for Rho family proteins share a similar fragment of 140 amino acids, known as the 
RhoGAP domain, which is sufficient to confer GAP activity.  
Activity of the Rho family GTPases is regulated cyclically. In the cytosol of resting 
cells, the GDP-bound GTPases form a complex with GDIs. It is believed that they 
maintain inactive Rho GTPases in the cytoplasm until an appropriate stimulus induces 
dissociation of the complex and concomitant exchange of bound GDP for GTP due to 
GEFs. In vitro studies have shown that binding of GDIs to Rho proteins not only 
prevents nucleotide exchange (thereby preventing activation) but also inhibits intrinsic 
and GAP-stimulated GTP hydrolysis (thereby preventing deactivation) (Chuang et al., 
1993; Takaishi et al., 1993). The GDIs can also extract Rho proteins from membranes 
and keep them in a soluble complex in the cytoplasm by possibly masking the 
membrane-binding prenyl group (Sanford et al., 1995).  
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1.9 Constitutively active and dominant inhibitory form of Rho GTPase 
The mutations of a number of conserved amino acids in Ras superfamily proteins 
decrease the intrinsic and GAP-stimulated GTPase activity, allowing these proteins to 
remain predominantly in the GTP-bound, active form. The proteins with mutations of 
12th amino acid from glycine to valine, or 61st amino acid from glutamine to leucine 
(number of RhoA), are the most commonly used constitutively active forms of Rho 
GTPases (Fig. 1.2).  
Dominant inhibitory forms of Rho proteins have been particularly useful in assessing 
their function. The most widely used dominant inhibitory Rho proteins are created by 
substituting amino acid 17 (number of RhoA) from threnine to asparagine (Fig. 1.2). 
The amino acid at this position is essential to coordinate with a Mg2+ ion required for 
guanine nucleotide binding in all Ras superfamily of GTP-binding proteins (Bourne et 
al., 1991). The substitution of this amino acid is therefore predicted to interfere with 
both Mg2+ and nucleotide binding, and indeed Rac and Cdc42 proteins with this 
mutation have a much lower affinity for GTP/GDP than their wild-type counterparts 
(Self and Hall, 1995). It is also believed that they inhibit the activity of their respective 
endogenous GTPases by competing for binding to GEFs (Feig, 1999). 
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H-Ras    MTEYKLVVVGAGGVGKSALTIQLIQNHFVDFYDPTIEDSYRKQWFTIDGET 
RhoA   MAAIRKKLVIVGDGACGKTCLLIVFSKDQFPEVYVPTVFENYVADIE—VDGKQ 
Rac1      MQTIKCVVVGDGAVGKTCLLISYTTNKFPSEYVPTVFDNYAVTVM—IGGEP 
Cdc42      MQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVM—VDGKP 
 
 
H-Ras    CLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYRFQI 
RhoA       VELALWDTAGQEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPE 
Rac1     VNLGLWDTAGQEDYDRLRPLSYPDTDVFLICFSLVSPASFENVRAKWYPE 
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Fig. 1.2.  Amino Acid sequence alignment of human H-Ras, RhoA, Rac1, and Cdc42 proteins. 
Common mutated amino acids for producing protein with altered behaviors are demonstrated in white 
letters: mutation of amino acid 12 and 61 generate GTPase-defective mutants, and mutation of amino 
acid 17 generates dominant inhibitory mutants. Numbers refer to RhoA. (Adopted from Ridley, 2000) 
1.10 Rac-mediated cytoskeleton organization  
The first characterized responses to Rho GTPases in mammalian cells link the 
plasma membrane receptors to the assembly and organization of the filamentous actin 
cytoskeleton. Rac regulates the formation of lamellipodia and membrane ruffles in 
a variety of cell types (Tapon and Hall, 1997). The lamellipodia are plasma 
membrane protrusions containing a meshwork of actin filaments. The membrane 
ruffles are similar in structure to lamellipodia, but protrude upwards from the dorsal 
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surface of adherent cells. Both lamellipodium extension and membrane ruffling 
require active actin polymerization at the plasma membrane.  
A number of Rac effectors act as regulators of actin polymerization. The p21-
activated kinase (PAK) that is activated by binding to active Rac or Cdc42, serves as a 
downstream effector for actin reorganization (Manser et al., 1997; Sells et al., 1997), 
leading to lamellipodium formation. IQGAP is another protein with potential role in 
cytoskeleton organization. It interacts with both Rac and Cdc42 and is localized to 
membrane ruffles. It appears to regulate cadherin-catenin interactions during cell 
adhesion and mediate actin reorganization (McCallum et al., 1998; Natale and Watson, 
2002). Rac can associate with phosphatidylinositol 5-kinase (PIP5-kinase) physically in 
vitro in a GTP-independent manner (Tolias et al., 2000). A complex of Rac with a type I 
PIP5-kinase and diacylglycerol kinase has been purified from cells (Tolias et al., 1998). It 
is suggested that PIP5-kinase stimulates actin polymerization probably by removing 
phosphoinositide-regulated capping proteins from actin filaments (Schafer et al., 1996). 
POR1 (partner of Rac) was found to interact specifically with Rac in a GTP-dependent 
manner and play a role in Rac-mediated membrane ruffling (Van Aelst et al., 1996). 
Arp2/3 complex is the only known cellular factor to nucleate new actin filament, and 
can be activated by nucleation-promoting factors (NPFs) to initiate actin 
polymerization (Welch and Mullins, 2002). During the formation of lamellipodia, Rac 
regulates Arp2/3 activity through NPFs WAVE/Scar (Miki et al., 1998). 
1.11 Rac in regulated exocytosis  
The trafficking of vesicles within cells involves the interactions with the actin 
cytoskeleton as well as with microtubules (Kelleher and Titus, 1998). The Rho family 
 Chapter 1 Introduction  
 - 22 - 
proteins can affect several aspects of vesicle trafficking, and the most significant role is 
inducing actin reorganization. 
In permeabilized mast cells, recombinant Rac proteins enhance secretion induced by 
various agents, although they cannot stimulate secretion by themselves (Brown et al., 
1998; O'Sullivan et al., 1996). Conversely, C3 transferase and dominant inhibitory Rac 
inhibit secretion induced by calcium and non-hydrolysable GTPγS (O'Sullivan et al., 
1996; Price et al., 1995). Rac was also purified from mast cells and neuroendocrine cells 
as a factor that can enhance secretion (Doussau et al., 2000; O'Sullivan et al., 1996). In 
natural killer cells, expression of dominant inhibitory Racl inhibit granule exocytosis 
(Billadeau et al., 1998). Using clostridial toxins to specifically inactivate certain 
members of Rho proteins in pancreatic β cells also imply that Rac and Cdc42 (rather 
than Rho) may be the candidate regulators implicated in stimulated insulin secretion 
(Kowluru et al., 1997b). However, the mechanisms underlying the involvement of Rho 
and Rac in exocytosis and secretion have not been established. It has been shown that 
phospholipids such as PIP2 and the kinases regulating their turnover serve as a link 
between Rho GTPases and actin cytoskeleton (Carpenter et al., 1999). Thus, it is possible 
that the local changes in membrane phospholipids, for example through activation of 
PIP5-kinase, PI3 kinase, or phospholipase D (PLD), may induce changes in actin-based 
cytoskeleton and regulate vesicle-target interaction (Martin, 1998).  
1.12 SNAREs machinery for exocytosis 
SNAREs (soluble N-ethylmaleimide-sensitive fusion protein [NSF] attachment protein 
[SNAP] receptors) represent a class of membrane-bound proteins that is defined by the 
presence of SNARE motif, a signature sequence of ~60 residues.. This motif mediates 
the assembly of SNAREs into an extremely stable coil-coiled core complexes during 
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fusion of vesicles with target membranes (Sutton et al., 1998). SNAREs are classified 
into two groups, the v-SNAREs and the t-SNAREs based on their localization on 
vesicle donor or target acceptor membranes. Another classification system is based on 
the conserved glutamine (Q) or arginine (R) in the SNARE motif (Fasshauer et al., 
1998). In practice Q-SNAREs are usually t-SNAREs and R-SNAREs are usually v-
SNAREs. A large number of SNARE proteins have been identified that act in different 
membrane-trafficking reactions all over the cell. Two groups of plasma membrane 
SNAREs (synaptosomal-associated protein-25 [SNAP-25] and syntaxins) interact with 
one group of vesicular SNARE (synaptobrevins, also called vesicle-associated 
membrane proteins [VAMP]) in exocytosis (Sollner et al., 1993). The first evidence 
that SNAREs, in particular the synaptic SNAREs syntaxin, SNAP-25, and 
synaptobrevin, are involved in membrane fusion is derived from the observation that 
botulinum and tetanus toxins specifically block synaptic vesicle exocytosis by 
attacking the synaptic SNARE proteins (Blasi et al., 1993; Schiavo et al., 1992). Each 
exocytotic SNARE has multiple closely related isoforms: SNAP-25 and -23; syntaxins 
1, 2, 3, or 4; and synaptobrevins 1, 2 and cellubrevin. Synaptobrevin/VAMP is a short, 
very abundant synaptic vesicle protein (~120 residues) composed of an N-terminal 30-
residue proline-rich sequence that is not well conserved between species, a central 
SNARE motif, and a COOH-terminal hydrophobic region (Sudhof et al., 1989; 
Trimble et al., 1988). SNAP-25, or synaptosomal protein of 25 kDa, is composed of 
two SNARE motifs that are connected by a long linker sequence containing multiple 
cysteine residues. SNAP-25 lacks a transmembrane region, and is attached to the 
membrane via multiple palmityl residues that are bound to the cysteine residues in the 
central region (Oyler et al., 1989). Syntaxin is similar to synaptobrevin in that it 
contains a COOH-terminal SNARE motif followed by a single transmembrane region 
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that anchors it in the membrane. Different from synaptobrevin, however, the N-
terminal sequence of syntaxin is relatively long (~180 residues) and forms an 
independently folded three-helical domain called the Habc domain (Fernandez et al., 
1998). In pancreatic β-cells, synaptobrevin, SNAP-25 and syntaxin are required in 
Ca2+-evoked exocytosis of insulin granules (Regazzi et al., 1995; Sadoul et al., 1995; 
Wheeler et al., 1996). SNAP-23, which is not cleavable by botulinum toxin, can 
replace the function of SNAP-25 in β-cells (Sadoul et al., 1997). Synapobrevin/VAMP 
can also be replaced by the isoform cellubrevin (Regazzi et al., 1996b). Syntaxin 
synthesis is regulated by glucose stimulation (Nagamatsu et al., 1997). NSF with 
adaptor proteins, rab proteins, and SM proteins (Sec1/Munc18-like proteins) are other 
three groups of proteins that co-work with SNAREs in exocytosis regulation. NSF is 
an ATPase that binds to SNARE complex via adaptor proteins SNAPs (Wilson et al., 
1989). It disassembles the core complexes in an ATP-dependent manner (Jahn and 
Sudhof, 1999). NSF is required for Ca2+-stimulated insulin secretion (Kiraly-Borri et 
al., 1996; Vikman et al., 2003). SM proteins are soluble proteins of ~65kDa that bind 
to syntaxin family. There are three Munc 18 isoforms, Munc 18a, b, and c. Munc18 
can bind to the closed conformation of syntaxin 1 (Dulubova et al., 1999). Therefore it 
may regulate the binding of syntaxins with SNAP-25 since syntaxins cannot 
simultaneously bind to SM proteins and other SNAREs (Pevsner et al., 1994). Rab 
proteins belong to another subfamily of small GTP-binding proteins that appear to be 
associated with specific fusion events. More than 60 Rab proteins are expressed in 
mammalian cells (Pereira-Leal and Seabra, 2000). Only 2 classes of Rab proteins (rab3 
and rab27) with a function in endocrine and synaptic exocytosis have been identified 
(Darchen and Goud, 2000; Yi et al., 2002). Rab3s are primarily regulatory, and appear 
to play a role only in regulated exocytosis. Rab3A is associates with secretory granules 
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in pancreatic β cells, while Rab3-interacting molecules such as RIM are localized at 
the plasma membrane (Iezzi et al., 2000; Inagaki et al., 1994; Regazzi et al., 1996a). 
Rab3A knockout mice are glucose intolerant and display a defect in glucose-induced 
insulin secretion (Yaekura et al., 2003). Overexpression of wild-type Rab27a and its 
GTPase-deficient mutant increase evoked insulin secretion in mouse β cells (Yi et al., 
2002). Silencing of Rab27a expression by RNA interference reduces the secretory 
capacity of β-cells (Waselle et al., 2003). Synaptotagmin is the most likely candidate 
for the Ca2+-sensor of the exocytotic machinery (Fernandez-Chacon et al., 2001), and 
essential for Ca2+-dependent neurotransmission and exocytosis of insulin-containing 
granules (Littleton et al., 1993; Lang et al., 1997). It is a protein of 65 kDa that spans 
the vesicle membrane once and contains a large cytoplasmic domain with two Ca2+-
binding C2 domains (protein kinase C-homology domains), C2A and C2B (Sutton et 
al., 1995). In addition to binding Ca2+, the C2 domains are involved in the association 
of synaptotagmin with phospholipids, SNAREs, and a variety of other proteins. 
Several isoforms of the protein have been identified, of which synaptotagmin III and 
synaptotagmin VII are present in β-cells (Gao et al., 2000; Lang et al., 1997). Beside 
synaptotagmin, syncollin and taxlilin are also potential Ca2+-dependent proteins 
involving exocytosis by binding with syntaxin (Edwardson et al., 1997; Nogami et al., 
2003). 
1.13. Aims of Studies 
Although Ca2+ is considered as the universal link in the stimulus-secretion coupling of 
regulated exocytosis, there is existence of Ca2+-independent, but GTP-dependent, 
exocytosis in both mast cells and pancreatic β-cells (Pinxteren et al., 2000; Metz et al., 
1992). The concept of a G protein (GE) controlling exocytosis is postulated and well 
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developed although it has yet to be identified (Gomperts et al., 1986; Gomperts et al., 
1990). It is believed that both heterotrimeric and monomeric GTP-binging proteins are 
involved in the control of exocytosis. On the other hand, it is well known that glucose 
stimulates insulin secretion from islet β-cells by both KATP-dependent and  
–independent signaling pathways; the former is mainly promoting [Ca2+]i rises 
whereas the nature of the latter remains to be defined with the G-protein to be a 
candidate.  
Previous studies ( Kowluru et al., 1997b; Daniel et al., 2002; Kowluru et al., 2003) 
have provided indirect evidence for the involvement of Rho subfamily of GTP-binding 
proteins in physiological insulin secretion. Such evidence came from the observations 
that stimulation of insulin secretion could be suppressed upon general inhibition of 
requisite post-translational modifications (i.e., farnesylation, carboxyl methylation, and 
fatty acylation) of small G-proteins, and when Rho subfamily GTP-binding proteins 
were selectively glucosylated and inactivated by Clostridial toxins (Aktories et al., 
2000; Kowluru et al., 1997b). However, Rho seemed not to play an important role in 
this event, since its inactivation by botulinum toxin C3 failed to affect stimulated 
insulin secretion (Kowluru et al., 1997b). In addition, it has been demonstrated  that 
under conditions of stimulated insulin secretion, glucose augmented the carboxyl 
methylation and membrane-association of Rho family of GTP-binding proteins 
(Kowluru et al., 1997a). All these findings suggested a possible involvement of Rho 
GTPases (potentially Rac or/and CDC42) in insulin secretion. Therefore, one of the 
aims of this study was to examine the putative regulatory role for Rac1, a low 
molecular weight small GTP-binding protein, in physiologic insulin secretion from 
insulin-secreting INS-1 cells, by studying its activation under physiological 
 Chapter 1 Introduction  
 - 27 - 
stimulation conditions and by modifying its activity through expressing of dominant 
inhibitory and constitutively active forms of its mutants. 
Syncollin was originally cloned from pancreatic acinar cells and the synthesized GST-
protein could interact with syntaxin in Ca2+-dependent manner and affect exocytosis in 
a cell-free system (Edwardson et al., 1996), at the time when this study was initiated 
while a collaborator independently cloned its gene from rat duodenum (Tan and Hooi, 
2000). Since this protein was found associated with zymogene granules, containing a 
19-amino acid N-terminal hydrophobic domain and interacting with syntaxin 
(Edwardson et al., 1996), all the typical properties of a v-SNARE, it would be logical 
to investigate its possible physiological role in exocytosis in an in vivo system. 
Although I was unable to detect its expression in β-cells and thus syncollin might not 
play a physiological role in insulin secretion, it was thought that such a well-
established exocytosis cell system could be useful to determine the possible function 
of syncollin in regulated exocytosis in vivo and improve the understanding of its 
biochemical features. To this end, the genes of syncollin and its truncated form (lack 
of N-terminal hydrophobic domain) were expressed in insulin-secreting INS-1 cells 
(not expressing syncollin) to investigate its effect on regulated exocytosis and the 
function of the hydrophobic sequence. 
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Chapter 2       
Materials and Methods 
2.1 Cells 
Insulin-secreting INS-1 cells and INS-1 derived cells (see a table below) were grown 
in RPMI 1640 (Sigma) containing 10% fetal bovine serum (GIBCO BRL), 50 µM 2-
mercaptoethanol and 1 mM pyruvate in culture flasks (Falcon) at 5% CO2. For 
transfected cell lines, additional antibiotics were added in culture medium for cell 
selection.  
Cells used in the study 
Cell type Origin Passage Culture medium 
INS-1 Rat 56-76 RPMI with 50 µM 2-
mercaptoethanol and 1 mM 
pyruvate (complete medium) 
INS-1 pIRES INS-1 Transfected with 
vector pIRES 
62-78 Complete medium + 50ug/ml 
hygromycin 
INS-1 N17Rac INS-1 Transfected with 
vector pIRES-N17Rac1 
62-78 Complete medium + 50ug/ml 
hygromycin 
INS-1 V12Rac INS-1 Transfected with 
vector pIRES-V12Rac1 
62-78 Complete medium + 50ug/ml 
hygromycin 
INS-1 pCDNA INS-1 Transfected with 
vector pCDNA 
62-76 Complete medium + 50ug/ml 
geneticin 
INS-1 syncollin INS-1 Transfected with 
vector pCDNA-syncollin 




INS-1 Transfected with 
vector pCDNA-truncated 
syncollin 
64-76 Complete medium + 50ug/ml 
geneticin 
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2.2 Molecular biology 
2.2.1  Buffers  
Buffers Composition 
Resuspension buffer for plasmid mini 
Prep 
50 mM Tris.Cl, pH 8.0; 10 mM EDTA; 10 
µg/ml RNase A 
Lysis buffer for plasmid mini Prep 200 mM NaOH, 1 % SDS 
Neutralization buffer for mini Prep 3.0 M potassium acetate, pH 5.5 
 
2.2.2  Bacterial strain  
XL1 blue E. coli strains (recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F′proAB 
lacIqZ∆M15 Tn10 (Tetr)]) were used for amplification of plasmids.  
2.2.3 Molecular cloning 
The plasmids with cloned human Rac1 mutants were constructed by subcloning into 
vector pIREShyg1 (Clontech, Palo Alto, CA, USA) from pEXVV12rac and 
pEXVN17rac. N-terminals of the mutants were tagged with c-Myc as a marker which 
can be recognized by an anti-c-Myc antibody. (This two constructs are generous gifts 
from Dr. Marie-Veronique Clement, National University of Singapore).  The dominant 
inhibitory mutant Rac1N17 has a mutated amino acid threonine 17 substituted by 
asparagine and the constitutively active mutant Rac1V12 has amino acid glycine 12 
substituted by valine. Control vector were constructed by deleting the inserts from 
above plasmids by 5’BamHI and 3’NotI restriction enzyme (Promega) digestion 
followed by blunt ligation using DNA polymerase I large (Klenow) fragment and T4 
ligase (Promega). Wild type Rac1 was cloned in to pIREShyg1 by using non-mutated 
forward primer followed by PCR, restriction enzyme digestion and ligation.  
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The two plasmids containing syncollin or its truncated form (lack of the N-terminal 
hydrophobic domain of 19 amino acids) were constructed by cloning them into vector 
pCDNA 3.1A/Myc-His (Invitrogen) by RT-PCR, in which 5’-accatgtccccgctgtgcct-3’ 
and 5’-tcaatagcacttgcagtaga-3’ were used as forward and reverse primers for syncollin 
while 5’-cgaggcgcttgtccagtgcc-3’ and 5’-tcaatagcacttgcagtaga-3’ were used as forward 
and reverse primers for the truncated syncollin. Empty vector was used as control 
plasmid. Myc-tagged syncollin was constructed by cloning syncollin in pCDNA 
3.1A/Myc-His without terminal codes.  
 
Plasmids used in the studies 
Plasmid Description 
pIRES Deleting the inserts from pIRES-N17Rac1 
pIRES-N17Rac1 5’ flank c-myc tagged N17Rac1 
pIRES-V12Rac1 5’ flank c-myc tagged V12Rac1 
pIRES-Rac1 5’ flank c-my tagged Rac1 
pCDNA pCDNA3.1A/Myc-His 
pCDNA-syncollin Syncollin was cloned in pCDNA3.1A  
pCDNA-truncated syncollin Truncated syncollin was cloned in pCDNA3.1A 
 
2.2.4 Transformation of E. Coli  
Purified plasmid DNA (50 ng) was added to 100 µl competent E.Coli cells, and mixed 
by swirling the tube gently followed by incubating on ice for 10 min. Cells were heat 
shocked by placing in 42oC water bath for 90 s followed by incubation of 2 min on ice. 
LB medium (400 µl) was added to each tube and incubated at 37oC for 1 hr on a 
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shaker (200 rpm). Bacterial culture (100 µl) was plated on the LB plate containing 100 
µg/ml ampicillin and incubated 12-16 hrs. 
2.2.5 DNA preparation 
Plasmid DNA Mini preparation 
Plasmid used for analysis was isolated by a modified protocol from Qiagen’s mini 
prepare kit. Bacteria (2-5 ml) were culture in LB medium overnight. Bacterial culture 
(1-2 ml) was transferred to 1.5 or 2 ml tubes and centrifuged at 11,000 g for 30 s. 
Supernatants were removed and the bacterial pellets were resuspended in 0.3 ml of 
resuspension buffer with RNase A. The bacteria should be resuspended completely, 
leaving no cell clumps. Afterwards, 0.3 ml of lysis buffer was added to the tubes, 
which were mixed gently by inverting 4–6 times and incubated at room temperature 
for 5 min. Thereafter, 0.3 ml of chilled neutralization buffer was added, mixed 
immediately but gently, followed by incubation on ice for 5 min. Lysate was 
centrifuged at maximum speed in a microcentrifuge for 10 min. Supernatants were 
transferred to new centrifuge tubes, and DNA was precipitated with 0.7 volume of 
isopropanol. The tubes were immediately centrifuged at 10,000 rpm for 30 min, and 
the supernatants were carefully decanted. DNA pellets were washed with 1 ml of 70% 
ethanol, air-dried for 5 min, and dissolved in a suitable volume of buffer. DNA 
concentrations were measured by UV spectrophotometry to determine the yield. 
Plasmid DNA Midi preparation 
Midi preparation of plasma DNA was carried out using Bio-Rad midi kit. Bacteria (30-
50 ml) were cultured in LB medium overnight. The culture was harvest at 6,000 g for 
15 min at 4oC in Beckman Centrifuge. The pellets were resuspended by pipetting in 4 
ml S1 buffer with RNase A, followed by adding 4 ml S2 buffer and mixing by 
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inverting 6-8 times. The tubes were then incubated 2-3 min at room temperature. 
Thereafter, 4 ml cold S3 buffer was added and mixed by inverting 6-8 times, followed 
by 5 min incubation on ice. The lysates were centrifuged at 12,000 g for 25 min at 4oC. 
The clear lysates were then loaded onto columns equilibrated with 2.5 ml N2 buffer. 
After the lysate flowed out, the column was washed with 10 ml N3 buffer. The 
plasmids were eluted with 5 ml N5 buffer and precipitated by adding 3.5 ml 
isopropanol, followed by centrifuging at 15,000 g for 30 min at 4oC. Subsequently, the 
pellets were washed with 2 ml 70% ethanol, and centrifuged at 15,000 g for 10 min at 
room temperature. Air-dried plasmids were dissolved in TE buffer and DNA 
concentrations were determined by UV spectro-photometry. 
Purification of DNA fragments from agarose gel 
The gels with DNA bands were chopped finely, followed by adding water to final 
volume about 300 µl. An equal volume of buffered phenol (Sigma) was added and 
mixed by vortex. The mixture was incubated in -80oC for 15 min, and centrifuged at 
14,000 rpm for 20 min at room temperature. The top aqueous layer was transferred to a 
new centrifuge tube and a half volume of buffered phenol and chloroform each was 
added, followed by centrifuging at 14,000 rpm for 5 min at room temperature. The top 
layer was transferred to a new centrifuge tube. One tenth volume of 3.0 M sodium 
acetate and 2 volume of cold pure ethanol were added, followed by incubating in -
20oC for 30 min and centrifuging at 14,000 rpm for 30 min at 4oC. The pellets were 
washed with 500 µl cold 70% ethanol and dissolved in TE buffer. 
Purification of DNA fragments from solution 
DNA by restriction enzyme digestion was purified by using GFX DNA purification 
Kit (Amersham). In brief, 500 µl capture buffer was added to the reaction buffer 
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containing DNA and restriction enzyme and mixed with pippetting. The volume of 
reaction buffer was topped to 100 µl and the mixture was transferred to a DNA 
binding column and incubated for 1 min at room temperature. The column was 
centrifuged at full speed in a common centrifuge for 1 min. Thereafter, 500 µl wash 
buffer was added to the column that was centrifuged. DNA was eluted by adding 
distilled water to the column followed by centrifuging. 
2.2.6  RNA purification 
Cells cultured in 60-mm dishes were used to isolate total RNA by using RNeasy Mini 
Kit (Qiagen). The culture medium was aspirated completely followed by adding 350 
µl buffer RLT (lysis buffe). Cell lysate was collected by scraping and mixed by vortex. 
The lysate was homogenized by passing 5 times through a 20G needle fitted to a 
syringe. One volume of 70% ethanol was added to homogenized lysate and mixed by 
pipetting. The mixture was transferred to an RNeasy mini spin column, and 
centrifuged for 15 s at 8,000 g. The column was washed by adding 700 µl Buffer RW 
and centrifuged for 15 s 8,000 g. Thereafter, the column was treated twice by adding 
500 µl buffer RPE and centrifuged for 15 s at 8,000 g and for 2 min at maximum speed 
in a regular centrifuge. RNA was recovered by eluting the column with 50 µl RNase-
free water. 
2.2.7 Polymerase chain reaction  
Reverse transcription 
Purified total RNA (0.5-2 µg) and 1 µl oligo dT (0.5 µg/µl) were added to DEPC 
treated water to final volume of 13.5 µl. The mixture was incubated at 70oC for 5 min 
and quickly chilled on ice. The reverse transcriptase buffer, reverse transcriptase and 
dNTPs were added to the mixture and the final volume was adjusted to 20 µl by 
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adding DEPC treated water. Reverse transcription was performed by incubating at 
42oC for 1 hr followed by inactivation of enzyme at 94oC for 5 min. 
Polymerase chain reaction 
Reaction mixture was prepared by adding 5 µl 10x PCR buffer, 0.5 µl PFU (2.5 
unit/µl), 1 µl dNTPs (10 mM), 2 µl RT product, and 1 µl each of forward and reverse 
primers. Final volume was adjusted to 50 µl. The PCR reaction was performed in PCR 
machine at the setting as follow: 
Step 1,  94 oC 5 min 
Step 2,  94 oC 30 s 
Step 3,  55-60 oC 45 s 
Step 4,  72 oC 1 min 
Repeat from step 2 to step 3 for 25-30 cycles, 
Step 5,  72 oC 4 min 
Step 6,  4 oC 
2.3  Transfection and cell selection 
2.3.1  Transfection using SUPERFECT 
On the day before transfection, 2–8 x 105 cells were seeded in 5 ml of appropriate 
growth medium in 60-mm cell culture dishes. The cell number seeded should produce 
40–80 % confluence on the day of transfection. The cells were then incubated at 37°C 
and 5% CO2 in an incubator overnight. Five µg of plasmid DNA dissolved in TE, pH 
7.4 (minimum DNA concentration: 0.1 µg/µl) was diluted with serum-free cell growth 
medium containing no antibiotics to a total volume of 150 µl. The solution was mixed 
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and spinned down for a few seconds to remove drops from the top of the tube. 
SuperFect transfection reagent (20 µl) (Qiagen) was added to the DNA solution, and 
mixed by pipetting 5 times or by vortexing for 10 s. The samples were incubated for 
5–10 min at room temperature (20–25°C) to allow complex formation. While complex 
formation was taking place, the culture medium in the dishes containing cells was 
aspirated and cells were washed once with 4 ml PBS. One ml of cell growth medium 
(containing serum and antibiotics) was added to the reaction tube containing the 
transfection complexes and mixed by pipetting twice. The whole transfection medium 
was immediately transferred to the cells in the wells. Cells were then incubated with 
the complexes for 2–3 hrs at 37°C and 5% CO2. Afterwards, transfection medium was 
aspirated and cells were washed 3–4 times with 4 ml of PBS. Thereafter, fresh cell 
growth medium (containing serum and antibiotics) was added, and cells were 
incubated for 24–48 hrs. Then cells were passaged at 1:10 to 1:15 splitting in the 
appropriate selecting medium, and cultured until clones appeared. 
2.3.2  Transfection using FUGENE6 
Cells were seeded in 6-well plates at density of 1-3 x 105 cells before the day of 
transfection, and incubated at 37°C and 5% CO2 overnight. The transfection 
reagent:DNA complex was prepared by mixing 3 µl FuGENE6 reagent (Roche 
Diagnostics) and 1 µg plasmid DNA in serum-free medium sequentially, followed by 
incubation for a minimum 15 min at room temperature. The complex mixture was 
drop-wisely added to cells without changing medium, and cells were continuingly 
cultured in an incubator for 2 days. Subsequently, cells were passaged into selecting 
medium and cultured until clones appeared.  
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2.3.3  Cell selection for stable expression of transgenes 
Transfected cells were continuing to culture in medium containing drugs (50 µg/ml 
hygromycin for Rac1 mutant transfected or 50 µg/ml geneticin for syncollin 
transfected cells, respectively) for a selection period of 4 weeks until individual clones 
were visible in culture dishes. The clones were then subcultured and used as 
polyclonal cell population for further experiments. These transfected polyclonal cells 
were verified by immunofluroscence staining and confocal microscopy to confirm the 
expression of transgenes in these cells (Fig. 3.2B demonstrated Rac1 mutant 
expression; Fig 3.19 revealed syncollin constructs expression).  After selection, all 
transfected cells were cultured in medium containing 25 µg/ml drugs to maintain the 
cells stably expressing transgenes. 
The cells used for experiments of intracellular co-localization of syncollin were 
performed by transient transfection for two days and directly for experiments without 
drug selection.  
2.4 Subcellular fractionation 
2.4.1 Buffers 
Buffer Composition 
Homogenization buffer 20 mM Tris-HCl, pH 7.4; 0.5 mM EDTA; 0.5 
mM EGTA; 0.25 M sucrose; 1 mM DTT; 10 
µg/ml leupeptin, 4 µg/ml aprotinin; 2 µg/ml 
pepstatin; 100 µM PMSF 
Medium A for plasma membrane 10 mM Tris-HCl, pH 7.4; 1mM MgCl; 0.25 M 
sucrose 
Medium B for plasma membrane 10 mM Tris-HCl, pH 7.4; 1mM MgCl; 2.0 M 
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sucrose 
HEPES-buffered saline (HBS) 50 mM HEPES, pH 7.6; 100 mM NaCl; 1 mM 
EDTA; 1 mM DTT; 1 mM PMSF; 1 µg/ml 
pepstatin 
 
2.4.2 Isolation of the plasma membrane 
Plasma membrane isolation was modified from Graham’s method (Graham, 1997). 
INS-1 cells (4.5 x 107) were harvested by scraping after twice washes with PBS. 
Thereafter, the cells were centrifuged at 800 rpm for 5 min and the pellet was 
resuspended in 1-2 ml homogenization buffer. The cells were homogenized by using a 
27G needle with a syringe for 10 strokes. The homogenate was centrifuged at 250 g 
for 5 min. The supernatant was transferred to new tubes and centrifuged at 1,500 x g 
for 10 min. The pellet was resuspended in 1 ml medium A and mixed well with 2 
volumes of medium B. The suspension was transferred to a 5-ml tube for a Beckman 
SW70 swing-bucket rotor, and filled by overlaying with 0.5 ml of medium A, followed 
by centrifuging at 113,000 g for 1 hr. The plasma membrane sheet at the interface was 
collected and diluted with 1 ml homogenization buffer and harvested by centrifugation 
at 3,000 g for 10 min. The pellets were resuspended in HBS and protein concentrations 
were quantified using Bio-Rad assay kit. 
2.4.3 Subcellular fractionation of organelles 
Subcellular fractions of INS-1 cells were separated as previously described (Li et al., 
1996). All procedures were performed on ice. About 4.5 x 107 cells grown in 15-cm 
dishes were washed twice with cold PBS and scraped in 1 ml homogenization buffer. 
The cells were then disrupted by 10 strokes through a 27G needle. The cell 
homogenates were centrifuged at 900 g for 10 min to remove the nuclei and unbroken 
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cells. Mitochondria-enriched, secretory-granule-enriched and microsomal fractions 
were isolated by centrifuging post-nuclear supernatants at 5,500 g for 15 min (in 
Eppendorf 5417R), 25,000 g for 20 min and 100,000 g for 60 min (in Beckman L-80), 
respectively. For the isolation of total membrane and soluble fractions, the post-
nuclear supernatants were centrifuged at 100,000 g for 60 min. All membrane fractions 
were resuspended in HBS. Protein concentrations in subcellular fractions were 
measured by Bio-Rad assay kit. 
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2.5 Protein analysis 
2.5.1 Buffers for protein analysis 
Buffer Description 
Lysis buffer 100 mM Tris-HCl, pH 8.0; 75 mM NaCl; 2 mM EDTA; 10 
% glycerol; 1 µg/ml aproptinin; 1 µg/ml leupeptin; 0.5 % 
Triton X-100; 0.1 mM PMSF 
Loading buffer (2x) 100 mM Tris-HCl, pH 6.8; 200 mM DTT; 20 % glycerol; 4 
% SDS;  0.2 % bromophenol blue 
SDS/PAGE buffer 0.1 mM sodium phosphate, pH 7.2; 0.1 % SDS 
Blotting buffer 20% methanol; 24 mM Tris base; 194 mM glycine 
Tris-buffered saline 
(TBST) 
20 mM Tris-HCl, pH 7.5; 150 mM NaCl; 0.2 % Tween-20;  
Blocking buffer TBST with 5 % non-fat milk powder 
 
2.5.2 Antibodies 
Antibody Dilution Supplier 
Anti-c-Myc, monoclonal 1:200 Roche Diagnostics 
Anti-Rac, monoclonal 1:1000 BD Bioscience 
Anti-PIP5K-Iα, polyclonal 1:1000 Santa Cruz 
Anti-Syncollin antiserum 1:40 Customer-ordered from 
GeneMed Synthesis, Inc., USA 
 
2.5.3 Sample preparation 
Cells cultured in dishes or multi-well plates were washed with cold PBS, scraped in a 
homogenizing buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1 mM 
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PMSF, and 10 µg/ml each of aprotinin, leupeptin, and pepstatin) by cell-lifers, and 
sonicated on ice 3 times (10 s each). The samples were stored at -70oC if not 
immediately used for Western-blotting. 
2.5.4 SDS/Polyacrylamide gel electrophoresis (PAGE) 
The 15% separating gel was prepared by mixing 6.7 ml monomer solution (30% 
Acrylamide/N,N’-methylenbisacrylamide solution), 5 ml 4X running gel buffer (1.5 M 
Tris-HCl, pH 8.8), 100 µl 10% SDS, 8.0 ml deionised distilled water, 100 µl 10% 
ammonium persulfate and 6.7 µl tetramethylethylenediamine (TEMED) in a total 
volume of 20 ml. The solution was well mixed and allowed to polymerize for at least 1 
hr. Stacking gel was prepared by mixing 0.59 ml monomer solution (30% 
Acrylamide/N,N’-methylenebisacrylamide solutions), 1.11 ml 4X stacking gel buffer 
(0.5M Tris-HCl, pH 6.8), 44 µl 10% SDS, 2.71 ml deionised distilled water, 22.3 µl 
10% ammonium persulfate and 2.3 µl TEMED. The mixture was overlaid on 
separating gel and allowed to polymerize for at least 1 hr. Proteins samples were 
loaded on the gel after mixing with loading buffer and heated at 95oC for 5 min, 
followed by electrophoresis (20mA per gel) for 1-2 hrs. 
2.5.5 Western blotting 
Proteins separated in SDS/PAGE were transferred to a nitrocellulose membrane in 
blotting buffer by constant voltage (90V) for 2 hrs. Blotting membrane was incubated 
in blocking buffer for 1 hr at room temperature, followed by three washes with TBST. 
Thereafter, the membrane was incubated with primary antibody diluted in blocking 
buffer for 1 hr at room temperature or overnight at 4°C in gentle rotation. Following 
three washes with TBST, the membrane was incubated in diluted HRP-conjugated 
second antibody for 1 hr at room temperature with gentle rotation. After three washes, 
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the membrane was immersed in freshly-prepared enhanced chemiluminescence (ECL) 
substrate solution for 5-10 min. Image exposure was performed by using X-ray film or 
ChemiDoc Image capturer (Bio-Rad). Density quantification of bands was determined 
by the software Quantity One (Bio-Rad). 
2.6  Measurement of Rac1 GTPase activity 
Rac1 activity was determined by a pull-down assay using GST-PAK-CD (CD denotes 
to CRIB domain) as a probe that solely binds to active Rac1-GTP and Cdc42-GTP 
(Malliri et al., 2002). INS-1 cells (~1 x 107) were incubated with 2.8 mM or 15 mM 
glucose for 30 min. The cells were then washed with ice-cold PBS and incubated for 5 
min on ice in 1 ml lysis buffer (50 mM Tris-HCl, pH 7.4, 30mM MgCl2, 1% Triton X-
100, 10% glycerol, 100 mM NaCl, 1 mM DTT, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 
and 1 µg/ml aprotinin). Cell lysate were harvested and centrifuged for 5 min at 21,000 
g at 4°C. Aliquots (100 µl) were taken from the supernatant for detecting total Rac1 
amount. The remaining supernatants were incubated with 20 µg GST-PAK-CD fusion 
peptide (a generous gift from Dr. Edward Manser, Institute of Molecular and Cell 
Biology, Singapore) and 25 µl 50% glutathione-Sepharose 4B beads (Amersham, UK) 
for 60 min at 4 °C with gentle agitation. The mixture was centrifuged at 500 g for 5 
min to sediment the matrix, followed by 3 washes with cold lysis buffer. The proteins 
were eluted by adding Laemmli sample buffer and boiled for 5 min. The eluted 
samples, including those supernatant aliquots, were subjected to SDS-PAGE and 
Western blotting as described above.  
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2.7  Immunofluorescence staining 
2.7.1 Commonly used solutions 
Solution Description 
Phosphate-buffered saline (PBS) 137 mM NaCl; 2.7 mM KCl; 4.3 mM 
Na2HPO4; 1.4 mM KH2PO4; pH 7.4 
Fix solution 3.7 % paraformaldehyde in PBS 
Permeabilization solution 0.2 % Triton X-100 in PBS 
Blocking solution 10 % fetal bovine serum in PBS 
2.7.2  Antibodies 
Antibody Dilution Supplier 
Anti-insulin, monoclonal 1:1000 Sigma 
Anti-Rac, monoclonal 1:20 BD Bioscience 
FITC conjugated anti-Rac, monoclonal 1:20 BD Bioscience 
Anti-c-Myc, polyclonal 1:20 Santa Cruz 
Anti-c-Myc, monoclonal 1:20 Roche Diagnostic 
Anti-calnexin, polyclonal 1:20 Santa Cruz 
Anti-Mn superoxide dismutase, polyclonal 1:500 StressGen, Victoria, Canada 
Rabbit anti-α-mannosidase II antiserum 1:1000 Dr. Kelley Moremer, 
University of Georgia, USA 
TRITIC conjugated anti-mouse IgG, 
monoclonal 
1:100 Sigma 
FITC conjugated anti-rabbit IgG, polyclonal 1:20 Sigma 
FITC conjugated anti-rabbit IgG, polyclonal 1:10 DAKO 
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2.7.3  Immunofluorescence microscopy 
INS-1 cells cultured on coverslips were washed twice in PBS (pH 7.4) and fixed for 10 
min at room temperature in 3.7% paraformaldehyde in PBS. Following 2 washes in 
PBS, the cells were permeabilized by 10-min incubation in PBS containing 0.2% 
Triton X-100. After 30 min blocking in PBS containing 10% fetal bovine serum, the 
cells were incubated in solution containing primary antibodies for 1 hour at room 
temperature. The coverslips were washed 6 times in PBS, and then incubated for 1 hr 
with TRITC/FITC-conjugated secondary antibodies (1:100 dilution) (Sigma, USA). 
Thereafter, coverslips were washed again 6 times in PBS and mounted on glass slides 
with fluorescence mounting medium (Dako, Carpinteria CA, USA). Samples were 
examined under laser confocal microscopy (Olympus IX 70 Fluoroview300 or Zeiss 
LSM510). 
2.7.4 Rhodamine-phalloidin staining of filament actin  
F-actin staining by phalloidin toxin was conducted as described previously (Li et al., 
1994). INS-1 cells were seeded on glass coverslips and cultured for 2 days. After 2 
washes with PBS (pH 7.4), cells on coverslips were fixed with 3.7% paraformaldehyde 
in PBS for 10 min. Cells were washed twice again and then incubated with 330 nM 
rhodamine-phalloidin (Molecular Probes, USA) and 300 ng/ml of 
lysophosphatidylcholine (Sigma, USA) for 20 min at room temperature. Subsequently, 
coverslips were washed twice with cold PBS and mounted on glass slides. The slides 
were examined by laser confocal microscopy (Olympus IX 70 Fluoroview300).  
2.8 Insulin secretion assay 
Insulin secretion was determined as described previously (Li et al., 1993). INS-1 cells 
were seeded in 24-well plates and cultured for 3-4 days in RPMI-1640 medium. For 
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secretion experiments, the cells were washed twice with fresh Krebs-Ringer-Hepes 
buffer (KRB) (containing in mM: 129 NaCl, 4.8 KCl, 1 CaCl2, 1.2 MgSO4Cl2, 5 mM 
NaHCO3, 1.2 KH2PO4, 2.8 glucose, and 10 Hepes, pH 7.4). After the cells were 
preincubated for 30 min in 0.5 ml KRB at 37oC, the buffer was replaced by 0.5 ml 
KRB containing secretagogues and the cells were incubated for the specified periods. 
The supernatants were removed for measurements of secreted insulin and the attached 
cells were extracted by acid-ethanol for determination of insulin content. Insulin was 
assayed by a radioimmunoassay kit (Linco Research, St. Charles, MO, USA). The 
rates of insulin secretion were expressed as percentages of insulin content to correct 
the possible influence of variations in the cell number between wells. 
2.9 Measurement of cytosolic free calcium 
Cytosolic free Ca2+ levels ([Ca2+]i) were determined as described previously (Li et al., 
2000). INS-1 cells (about 20 x 106) in flasks were trypsinized according to standard 
procedures. After washing, cells were resuspended in 50 ml RPMI-1640 medium 
supplemented with 1% new born calf serum and 20 mM Hepes, and kept in a spinner 
for 3 hrs at 37°C. Then the cells were washed once and resuspended in 20 ml spinner 
medium supplemented with 10% fetal calf serum, and left for 10 min at 37°C. 
Subsequently, the cells were loaded with a fluorescent Ca2+ probe by incubation with 1 
µM Fura-2/AM for 30 min at 37°C. After washing, cells were aliquoted and about 2 × 
106 cells in 2 ml of KRB were transferred to a glass cuvette. Stimuli were added to the 
cuvette after equilibration of cells at 37° for ~10 min. Fluorescence was recorded by a 
spectrofluorometer (Perkin Elmer LS-50B), with excitation and emission wavelengths 
of 340 and 505 nm, respectively. Unless specified, the contaminating fluorescence 
from extracellular Fura-2 was assessed by adding 50 µM Mn2+ (which was then 
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chelated by adding 100 µM diethylenetriaminepentaacetic acid) and was subtracted 
accordingly for each trace. Calibration of fluorescent signals into [Ca2+]i values was 
carried out by a formula described previously (Li et al., 2000). 
2.10  Measurement of membrane potential 
Membrane potential of INS-1 cells was monitored using a voltage-sensitive 
fluorescent probe, bisoxonol, as described previously (Li et al., 2000). The anionic dye 
binds to the plasma membrane; its fluorescence is increased when cells are depolarized 
and decreased when cells are hyperpolarized. About 2 × 106 cells in KRB buffer were 
placed in a cuvette. Bisoxonol (final 100 nM) was added and cells were left at 37°C for 
about 15 min for equilibration. Fluorescence was recorded with excitation and 
emission wavelengths of 540 and 580 nm, respectively. For comparison and statistical 
analysis, the bisoxonol fluorescent signals were normalized by expression of results as 
the percentage of a near-maximal depolarization achieved by 40 mM KCl in each 
trace. 
2.11 Assessment of nutrient metabolism by MTS test 
Nutrient metabolism of the cells was monitored using an MTS assay kit (CellTiter 
96tm) developed by Promega. INS-1 cells were seeded onto 96-well plates and cultured 
in the presence of test agents for various periods. A mixture of MTS and PMS 
(phenazine methosulfate; an electron coupling reagent) (final concentrations 333 and 
25 µg/mL, respectively) was added, and cells were incubated for 30 min at 37°. The 
reaction was stopped by the addition of 10% SDS if samples were not subjected 
immediately to the determination of absorbance. Formazan formed from reduction of 
MTS (Cory et al., 1991) was quantitated by measurement of absorbance of the medium 
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at 490 nm using a microplate reader. All data have been corrected for background 
signals. 
2.12  Statistical analysis 
Data were expressed as mean ± SEM and statistically analyzed by two-tail paired or 
unpaired t-test depending on individual experiments. 
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Chapter 3       
Results 
Part I:  The role of Rac1 in glucose and forskolin stimulated insulin 
secretion in insulin-secreting β (INS-1) cells 
3.1 Background 
The Rho family of small GTP-binding proteins contains more than 10 members in 
mammals including Rho, Rac and CDC42 that are most well studied (Hall, 1998; 
Ridley, 1996). The Rho proteins are primarily involved in the regulation of actin 
cytoskeleton organization and are important for cell adhesion, migration, phagocytosis, 
cytokinesis and other morphological changes such as formation of ruffles, 
lamellipodial and filopodial extensions (Billadeau et al., 1998; Gasman et al., 1998; 
Hall, 1998; Hong-Geller and Cerione, 2000; Tatsumoto et al., 1999). In addition, there 
is evidence for the implication of Rho proteins and actin filaments in regulated 
exocytosis, although their actions seem quite complex (Aunis and Bader, 1988; Hall, 
1998). The actin network beneath the plasma membrane was transiently 
depolymerized during exocytosis in mast cells and chromaffin cells (Koffer et al., 
1990; Rose et al., 2001). Thus it appeared that the cortical actin cytoskeleton web acts 
as a barrier to hamper the access of secretory granules to the plasma membrane and a 
reorganization of F-actin in this region occurs during the late steps of exocytosis. In 
pancreatic β-cells, disrupting F-actin by cytochalasin B facilitated insulin release 
(Jijakli et al., 2002), in particular during the first phase (Li et al., 1994). On the other 
hand, maintenance of F-actin structure is also required for secretory process. For 
instance, an increase of F-actin was observed when pancreatic β cells were stimulated 
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by glucose (Swanston-Flatt et al., 1980), and cholecystokinin-induced exocytosis in 
permeabilized pancreatic acinar cells was inhibited when the highly concentrated 
monomeric actin binding protein β-thymosin was introduced (Muallem et al., 1995). 
Moreover, disruption of F-actin filaments by using Clostridium botulinum C2 toxin 
preferably reduced the second phase of insulin secretion from islet β-cells (Li et al., 
1994). Thus, the basic substructure of actin cytoskeleton may also be essential for the 
normal recruitment of secretory granules to the plasma membrane. In addition, actin 
network may provide contractile forces that expel the granule contents (Valentijn et 
al., 1999), since earlier studies had demonstrated that inhibition of myosin light chain 
kinase reduced insulin secretion from β-cells (Li et al., 1994). 
It was uncertain that Rho proteins participated in the modulation of exocytosis through 
regulating cytoskeleton reorganization or by other mechanism. Rho A is possibly 
involved in exocytosis in chromaffin cells by regulating phosphatidylinositol-4-kinase 
(Gasman et al., 1998). However, inactivation of Rho by botulinum toxin C3 did not 
affect stimulated insulin release (Kowluru et al., 1997b). It appeared that Rac proteins 
are particularly interesting for this context as evidenced in several secretion systems, 
including mast cells, chromaffin cells and neuronal cells (Brown et al., 1998; Doussau 
et al., 2000; Gasman et al., 1999; Komuro et al., 1996; Price et al., 1995). At least 
three Rac isoforms have been identified in mammals. Rac1 is ubiquitously expressed 
(Haataja et al., 1997; Moll et al., 1991), while Rac2 is a hematopoietic-specific and 
Rac3 is highly expressed in brain (Haataja et al., 1997; Shirsat et al., 1990). Rac3 
shares 92% and 89% amino acid identity with human Rac1 and Rac2, respectively 
(Haataja et al., 1997). Application of Rac mutants in permeabilized cells is a direct 
approach to observe its instant effect on secretion. It was found that constitutively 
active Rac enhanced regulated secretion whereas dominant-inhibitory Rac exhibited 
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opposite effects in permeabilized mast cells (Brown et al., 1998; Price et al., 1995). 
Studies using clostridial toxins to specifically inactivate certain members of Rho 
proteins in pancreatic β cells also implied that Rac and Cdc42 rather than Rho may be 
the candidate regulators implicated in stimulated insulin secretion (Kowluru et al., 
1997b).  
The mechanism of possible role of Rac GTPase, such as its response to glucose 
stimulation, in regulated insulin secretion was unclear. Therefore, in the present study 
dominant inhibitory or constitutively active Rac1 mutants were expressed in insulin-
secreting INS-1 β cells to address this question.  
3.2 Differential distribution of expressed Rac1 mutants from endogenous 
Rac1  
In control INS-1 cells (transfected with empty vectors), the endogenous Rac1 was 
mainly present in cytosol even though trace amounts were detected in the fractions 
enriched with mitochondria and secretory granules, as assessed by Western-blotting 
(Fig. 3.1A). The examination by immunofluorescence staining indicated that native 





Fig. 3.1. Distribution of endogenous Rac1 in INS-1 
cells. (A) Immunoblotting detection of Rac1 in 
subcellular fractions. Cells were homogenized and 
separated by differential centrifugation to obtain 
mitochondria-rich (MT), insulin granule-rich (G), 
microsomal (MS) and cytosol (C) fractions. Equal 
amount (20 µg) of proteins from each fraction was 
separated by SDS-PAGE and probed by an anti-Rac1 
monoclonal antibody. Data are the representative of at 
least 4 experiments with identical results. (B) 
Immunofluorescence staining of Rac1 in INS-1 cells 
was probed by anti-Rac1 monoclonal antibody and 
TRITC conjugated anti-mouse IgG. Bar=5 µM 
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The cells expressing Rac1-mutants used for the experiments were polyclonal cells 
derived from stable trnasfection through selection with antibiotic hygromycine (Roche 
Diagnostic) and verified by using Western blotting and immunifluorescence staining. 
A majority of the transfected cells were positive for the mutant proteins (Fig. 3.2B). 
An antibody recognizing exclusively Myc-tagged proteins was employed for 
immunofluorescence staining of Rac1 mutants that contain the tag. No signal could be 
detected in control cells in this way (Fig.3.2). Although the staining in dominant 
inhibitory N17Rac1 transfected cells was observed primarily in the soluble 
compartment, considerable staining dots were also detected around the cell periphery 
(Fig. 3.3, left panel). The constitutively active V12Rac1 was more evenly distributed 
in the cells (Fig. 3.3, right panel). Western blot analysis of the subcellular 
fractionations yielded additional details of the localization of Rac1 mutants in 
transfected cells (Fig. 3.4). In contrast to the endogenous Rac1 that was mainly 
localized in the cytosol, N17Rac1 was primarily detected in the fractions enriched with 
mitochondria or insulin granules (Fig. 3.4, lane 1). However, V12Rac1 was distributed 
in all fractions including the microsomal and cytosolic fractions (Fig. 3.4, lane 3). 
These results reveal differential distribution patterns for the endogenous and mutated 
Rac forms among various subcellular fractions.   
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        Fig. 3.2. Identification of INS-1 cells stably expressing Rac1 mutants after hygromycin selection. A. 
Western blotting assay by using anti-c-Myc antibody demonstrated that the transfected cells express Myc-tagged 
Rac1 mutants. β-actin was used as internal control. B. Immunofluorscence staining by using anti-c-Myc 
antibody and TRITC conjugated anti-mouse IgG verified polyclonal cell population after hygromycin selection in 
Rac1 mutants.stably transfected INS-1 cells.  Images were detected by Olympus IX70 Fluoroview 300 laser 







Fig.  3.3. Intracellular localization of stably expressed Rac1 mutants in Ins-1 cells. Stably expression of Rac1 
mutants, N17Rac1 and V12 Rac1, in INS-1 cells was examined by immunofluorescence staining with anti-c-Myc 
monoclonal antibody and TRITC-conjugated anti-mouse IgG. Images were detected by Olympus IX70 Fluoroview 





Vector   N17Rac1  V12 Rac1
A
B Vector N17Rac1 V12Rac1
N17Rac1 V12Rac1
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Fig. 3.4.  Distribution of Rac1 mutants in INS-1 cells. Cells 
transfected by Rac1 mutants were incubated for 30 min in the 
presence or absence of 15 mM glucose plus 1 µM forskolin. 
The cells were then homogenized and subcellular fractions 
were isolated by differential centrifugation. Equal amount (20 
µg) of proteins in each fraction was separated by SDS-PAGE 
and probed by immunoblotting with anti-c-Myc antibody. Data 
are the representative of at least 5 observations 
3.3 Glucose specifically stimulates translocation of Rac1 from cytosol to 
membranes in control, but not in cells expressing the mutated Rac1 
When control INS-1 cells were stimulated by 15 mM glucose for 30 min, there was an 
increase of Rac1 in the membrane fraction with a concomitant reduction in cytosol 
(Fig. 3.5B). Relative abundance of Rac1, expressed as its membrane to cytosolic ratio, 
was significantly increased (1.57 fold; from 0.19 ± 0.02 to 0.49 ± 0.04) following 
exposure to glucose (Fig. 3.5A). The cAMP-elevating agent forskolin (1 µM) did not 
significantly affect the degree of Rac1 translocation elicited by glucose. Time course 
of glucose-induced Rac1 translocation revealed that such an effect reached 
significance at 15 min (Fig. 3.5C). Further studies revealed that glucose treatment is 
able to specifically facilitate translocation of Rac1 into the plasmalemma fraction from 








Glucose − +          − +
Forskolin − +         − +
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Fig. 3.5.  Glucose-induced translocation of Rac1 in INS-1 cells. (A and B) Following stimulation of 
cells with 15 mM glucose alone or 15 mM glucose plus 1 µM forskolin for 30 min, the total membrane 
fraction and cytosolic fraction were isolated (see Methods for additional details). The fractions from 
control and Rac1 mutant-transfected cells were first probed by immunoblotting using an anti-Rac1 
monoclonal antibody recognizing both native and mutated Rac1. Thereafter, the membranes were 
striped and an anti-c-Myc monoclonal antibody was used to probe Rac1 mutant in transfected cells.  β-
actin was used as internal control. The data in (A) denote the total Rac1 translocation. (C) Time course 
of glucose-induced Rac1 translocation in control INS-1 cells. Data are the representative of at least 4 
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Fig. 3.6.  Translocation of Rac1 to the plasmalemma by glucose. Following stimulation of cells by 
15 mM glucose alone or plus 1 µM forskolin for 30 min, plasmalemma were prepared and probed by 
immunoblotting using an anti-Rac1 monoclonal antibody. Thereafter, the membranes were striped 
and an anti-c-Myc monoclonal antibody was used to probe Rac1 mutant. The bar graph denotes the 
total Rac1 in the plasmalemma. Data are the representative of at least 4 observations. * P<0.05 vs. 
control. 
In contrast, stimulating cells with 15 mM glucose plus forskolin for 30 min did not 
alter Rac1 distribution between cytosol and membranes in either Rac1 mutant 
transfected cells (Fig. 3.4, lanes 2 and 4), when probed by an antibody that recognized 
solely the Myc-tagged Rac1 mutants. Interestingly, even though the basal levels of 
membrane-associated Rac1 were higher in transfected cells compared to those 
expressing the vector alone (e.g., by 32% and 62% in N17Rac1- and V12Rac1-
transfected cells, respectively) when assessed by an antibody that recognized both 
endogenous Rac1 and transfected Rac1 mutants, further stimulation of these cells 
expressing the mutants by glucose failed to induce Rac1 translocation from cytosol to 
the membranes (Fig. 3.5), including plasmalemma (Fig. 3.6). With the same approach, 
no apparent difference could be observed in the total Rac1 (both endogenous and 
mutated) contents in cell homogenates between the two Rac1 mutant-transfected cells 
and control cells (Fig. 3.7), indicating that there was no apparent over-expression of 
Rac1 mutants in the stably transfected INS-1 cells. These data suggest that glucose is 
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able to facilitate translocation of Rac1 (an indication of Rac1 activation) only in 




V12Rac1 Control   N17Rac1
Fig. 3.7 Expression of Rac1 mutants does not 
affect the total Rac1 level in INS-1 cells. 
Immunoblotting assay for lysates (40 µg) of Rac1 
mutant and empty vector transfected cells was 
performed by using anti-Rac1 antibody. Actin (42 
Kd) was used as internal control. The Myc-tagged 
Rac1 has slightly larger molecular mass than that of 
the endogenous Rac1 becuase the c-Myc sequence 
used as a tag contains only 10 animo acids 
(EQKLISEEDL). 
3.4 Glucose increases Rac1 activity as assessed by measuring active GTP-
Rac1  
Activation of Rac1 by glucose was confirmed by the direct detection of Rac1 GTPase 
activity. By using a fusion peptide (GST-PAK-CD) that is solely bound to the 
activated Rac1 (GTP-Rac1) as a probe (Malliri et al., 2002), GTP-bound Rac1 (i.e. 
elevation of Rac1 activity) was significantly increased  by 15 mM glucose stimulation 
in control INS-1 cells over 30 min (Fig. 3.8). The Rac1 activity stimulated by high 
glucose was attenuated in dominant inhibitory Rac1 transfected cells (Fig. 3.8). A 
strong signal of GTP-bound Rac1 was observed in the cells expressing constitutively 
active Rac1 mutant and glucose stimulation was unable to further increase the 
activation (Fig. 3.8)   
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Fig. 3.8.  Increase of activated Rac1 (Rac1-
GTP) by glucose stimulation in INS-1 cells. 
A pull-down assay using GST-PAK-CD was 
utilized to detect the activated Rac1 in INS-1 
cells after incubation with 2.8 or 15 mM 
glucose for 30 min (upper panel). Total Rac1 
contents and Rac1 mutants in the lysate 
samples (20 µg proteins) were shown in the 
lower panel. Rac1 was probed by Western 
blotting as detailed in the Methods section. 
Data are the representative of 3 independent 
observations. 
3.5 Dominant negative Rac1 causes marked morphological change in INS-1 
cells 
The control INS cells grew in monolayer on the culture surface with substantial 
lamellipodia (Fig. 3.9A). Remarkable changes in the morphology occurred in 
N17Rac1-transfected cells, which had less lamellipodia (a known morphological 
marker of Rac function (Hall, 1998) and tended to aggregate and stack (Fig. 3.9B). 
These cells rounded up and their ability to adhere to the substratum was also weaker 
since they were more easily detached by trypsinization. Besides, the size of these cells 
was significantly smaller (diameter of 9.9 vs. 12.6 nm of control cells) in suspensions. 
By contrast, INS-1 cells expressing the constitutively active V12Rac1 only revealed 
slight morphological changes, including more protrusions (Fig. 3.9C). In addition, the 
adhesion of these cells to substratum was relatively stronger (more resistant to 
trypsinization). These observations indicated that active Rac1 may be important for 
INS-1 cells to maintain normal morphology.  
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Control              N17Rac1            V12Rac1
 
Fig. 3.9.  Effects of expressing Rac1 mutants on INS-1 cell morphology. Cells were cultured in 
coverslip chambers. Living cell morphology was examined under differential interference contrast 
(DIC) by laser confocal microscopy. Images are the representative of at least 5 observations. Bar = 50 
µm. 
3.6 Expression of Rac1 mutants results in marked disruption of F-actin 
filaments in INS-1 cells  
The observed morphological changes, as indicated above, might be due to the 
interference with cytoskeleton organization in the transfected cells. In support of such 
a formulation, the control INS-1 cells displayed strong F-actin distribution in cell 
periphery and also some filaments in the interior of cells, as assessed by rhodamine-
phalloidin staining (Fig. 3.10, left). By contrast, F-actin staining in dominant inhibitory 
N17Rac1 transfected cells almost completely disappeared (Fig. 3.10, middle). It may 
be mentioned that even though some modest degree of reduction of F-actin staining 
was observed in constitutively-active V12Rac1 transfected cells, structure of F-actin 
filaments remained largely intact in these cells (Fig. 3.10, right). These findings 
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Vector N17Rac1 V12Rac1
Fig. 3.10.  F-actin organization in INS-1 cells expressing Rac1 mutants. Cells cultured on coverslips 
were fixed and stained by rhodamine-phalloidin which selectively binds to F-actin. The stained cells 
were examined by laser confocal microscopy. The images are the representative of 5 independent 
experiments. Bar = 20 µm. 
 
3.7 Expressing dominant negative Rac1 inhibits glucose- and forskolin-
stimulated insulin secretion in INS-1 cells 
Stable expression of dominant inhibitory or constitutively-active Rac1 mutants did not 
alter either the insulin contents in INS-1 cells (see Table 3.1; p.65), or the basal insulin 
secretion (Fig. 3.11). Insulin secretion from control cells over 30 min was increased by 
90% following exposure of these cells to 15 mM glucose. Simultaneous incubation 
with glucose (15 mM) and forskolin (1 µM) resulted in marked stimulation of insulin 
secretion (>290%) from these cells (Fig. 3.11). Expression of dominant inhibitory 
N17Rac1 significantly inhibited glucose-induced (>50%) and glucose plus forskolin-
induced (60%) insulin secretion (Fig. 3.11). However, insulin release induced by 
glucose alone or glucose plus forskolin was not significantly affected in cells 
expressing constitutively-active V12Rac1. In addition, high potassium-stimulated 
secretion was moderately, but not significantly, reduced in cells transfected with either 
of the Rac1 mutants (Fig. 3.11). These data indicated that Rac1 might be involved in 
glucose and forskolin stimulated insulin secretion from INS-1 cells, and such 
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regulatory effects of Rac1 appear to take place at steps prior to initiation of exocytosis 
by Ca2+, since insulin secretion elicited by a membrane-depolarizing concentration of 































Fig. 3.11.  Inhibition in glucose- and 
glucose plus forskolin-induced insulin 
secretion from INS-1 cells expressing 
dominant negative Rac1 mutant. Cells 
were cultured in 24-well plates. After 
stimulation of cells by secretagogues for 30 
min, insulin secretion and insulin content 
were measured by RIA. The values are 
mean ± SEM of at least 5 independent 
experiments in triplicates. Glc, glucose; 
FSK; forskolin. * P<0.05 and ** P<0.01 vs. 
control.  
Furthermore, stable expression of wild type Rac1 (Fig. 3.12A) also did not alter 
secretagogues-induced insulin release (Fig. 3.12B) and morphology of these cells 
remained unchanged, suggesting the specific N17Rac1 effects due to interference with 
Rac1. These data indicated that Rac1 may be involved in glucose and forskolin 





























Fig. 3.12.  No alteration of secretagogues-
stimulated insulin release by expression of 
wild Rac1 in INS-1 cells. A, INS-1 cells were 
transfected by c-myc-taggered wild Rac1 or 
empty vectors (control), and stably selected by 
hygromycin. Expressed wild Rac1 was detected 
by Western blotting of cell homogenates (20 µg 
protein) using an antibody against c-myc.  B, 
Cells cultured in 24-well plates were first 
preincubated for 30 min in KRB and then 
incubated with 2.8 mM glucose (basal) or 
specified secretagogues for 30 min. Insulin 
secretion and insulin content were measured by 
RIA. The values are mean ± SEM of 3 
independent experiments in triplicates. Glc, 
glucose; FSK; 1 µM forskolin.  
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3.8 Expression of dominant negative Rac1 mutant leads to inhibition of the 
late phase of glucose plus forskolin-stimulated insulin secretion 
It is well known that glucose evokes biphasic pattern of insulin secretion from islet β-
cells and each of the two phases are felt to be controlled by different mechanisms 
(Bratanova-Tochkova et al., 2002; Henquin et al., 2002; Rorsman et al., 2000). To 
determine the possibly distinct roles of Rac1 in the two phases, insulin secretion from 
the dominant inhibitory Rac1 transfected cells was measured during two consecutive 
stimulating periods (15 min as early phase and followed by a 20 min incubation 
reflecting the late phase), an approach used previously by other peers to study the early 
and late phase insulin secretion responses to glucose in isolated islets (Nesher et al., 
1989). The potentiating effect of forskolin on glucose-stimulated insulin secretion was 
greater (by 165%) in the late phase than the early phase (by 101%) in the control cells 
(Fig. 3.13). In cells expressing N17Rac1, the early phase of insulin release stimulated 
by glucose plus forskolin was significantly inhibited (-42%), albeit without significant 
effect on the release elicited by glucose alone (Fig. 3.13A). Furthermore, in cells 
expressing the dominant negative form of Rac, the degree of insulin secretion induced 
by either glucose alone or plus forskolin during the late phase was markedly inhibited 
by 63% and 49%, respectively (Fig. 3.13B). These results implicated that functional 
activation of Rac is essential for the late phase of insulin release, an effect that may be 
related to the Rac1 translocation (activation) by glucose during this period (cf. Fig. 
3.5C). 
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Fig. 3.13.  Effects of dominant inhibitory Rac1 expression on the two static phases of insulin 
secretion induced by glucose and forskolin. Cells cultured in 24-well plates were stimulated by 15 
mM glucose alone or plus 1 µM forskolin for 15 min incubation and the medium was removed for 
determination of the early secretion event. Afterwards, the cells were incubated with the fresh solution 
containing the same stimuli for another 20 min for assessment of the late phase secretion. The values are 
mean ± SEM of at least 3 independent experiments in triplicates. FSK; forskolin. **P<0.01 vs. control. 
3.9 Glucose induces translocation of PIP5K-Iα from cytosol to membranes 
in control INS-1 cells, but not in cells expressing mutated Rac1 
Based on the above observation of Rac1 translocation upon the stimulation of glucose, 
it was expected that Rac1 downstream effectors might be brought to the membranes 
where they interacts with Rac1. PIP5K-Iα, an isoenzyme of phosphatidylinositol-4-
phosphate 5’-kinase, is an effector of Rac capable of directly interacting with Rac in a 
GTP-independent manner (Tolias et al., 2000). Its product, phosphatidylinositol-4,5-
diphosphate (PIP2) is also a potential regulator of actin cytoskeleton organization and 
may play a role in the process of priming for exocytosis (Hay et al., 1995). It is thus 
possible that PIP5K-Iα may mediate the effect of Rac1 on the regulated insulin 
secretion.  
When control cells were stimulated by 15 mM glucose for 30 min, the membrane to 
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± 0.13 to 6.55 ± 1.87) (Fig. 3.14). Addition of 1 µM forskolin further enhanced the 
effect (3.2 fold; from 3.65 ± 0.13 to 11.81 ± 2.44). However, these effects of glucose 
and forskolin on PIP5K-Iα translocation were not observed in the cells stably 
transfected with either dominant inhibitory Rac1N17 or constitutively active Rac1V12 
(Fig. 3.14). The similar translocation pattern of PIP5K-Iα to that of Rac1 over glucose 
stimulation suggested a potential role of PIP5K-Iα in mediating the action of Rac1 on 
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Fig. 3.14.  Glucose-induced translocation of PIP5K-Iα in INS-1 cells. (A and B) Following 
stimulation of cells with 15 mM glucose alone or 15 mM glucose plus 1 µM forskolin for 30 min, the 
total membrane fraction and cytosolic fraction were isolated. The fractions from control and Rac1 
mutant-transfected cells were probed by immunoblotting using an anti-PIP5KIα polyclonal antibody. 
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3.10 Dominant inhibitory Rac1-mediated inhibition of insulin secretion does 
not appear to affect nutrient metabolism, membrane potential and [Ca2+]i 
increases  
To investigate the possible effects of dominant inhibitory Rac1 on the upstream 
signaling events in insulin secretion, nutrient metabolism, membrane potential and 
[Ca2+]i increment were also examined upon stimulation of INS-1 cells. Incubation of 
control cells with 15 mM glucose for 30 min increased MTS reduction (reflecting 
metabolism) by about 3 folds over basal; an effect not significantly influenced by the 
expression of either Rac1 mutants (Table 3.1). In addition, there were no significant 
differences in either resting membrane potential or depolarization (induced by 15 mM 
glucose, 100 µM ATP, or submaximal KCl) between control and N17Rac1 transfected 
cells (Fig. 3.15, A-D and Table 3.1). Furthermore, [Ca2+]i increments were also not 
affected by the expression of dominant inhibitory Rac1 when cells were stimulated by 
15 mM glucose or 34 mM KCl (Fig. 3.15, E-H and Table 3.1). These findings 
suggested that functional activation of Rac1 may not be a prerequisite for the 
generation of proximal signals required for the exocytotic secretion of insulin in INS-1 
cells elicited either by glucose or KCl.  
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Fig. 3.15.  Effects of expression of Rac1 mutants on membrane depolarization and [Ca2+]i under 
various stimulating conditions. A-D: Membrane potential of INS-1 cell suspensions was monitored 
with the voltage-sensitive fluorescent probe bisoxonol. Increase of fluorescence (upward) indicates 
depolarization. The results were expressed as percentage of the depolarizing signal achieved with a 
saturating concentration of KCl (40 mM) for each trace. The large, transient spikes are the artifacts 
caused following addition of test agents whereas the sustained changes reflect the true steady state 
values. E-H: [Ca2+]i in INS-1 cell suspensions was measured using a fluorescent probe (fura-2) as 
detailed in the Materials and Methods section. All traces are representatives of at least 3 observations in 
each case. The indicated values of KCl additions in the figure denote the final concentrations reached in 
the medium; basal K+ concentration was 6 mM. Glc; glucose. 
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Table 3.1. No changes in insulin content, MTS test, membrane potential and 
[Ca2+]i profile by transfection of Rac1 mutants in INS-1 cells 
 Control N17Rac1 V12Rac1 
Insulin content  
(ng/ng DNA) 
0.52 ± 0.07 (4) 0.50 ± 0.10 (4) 0.49 ± 0.06 (4) 
Formazan production  
at glucose-free  
(arbitrary unit/106 cells) 
0.45 ± 0.05 (4) 0.46 ± 0.06 (4) 0.48 ± 0.06 (4) 
Formazan production  
by 15 mM glucose 
(arbitrary unit/106 cells) 
1.15 ± 0.12 (4) 0.93 ± 0.10 (4) 1.09 ± 0.13 (4) 
Rest membrane potential  
(% maximal effect) 
62.9 ± 1.1 (6) 61.6 ± 2.1 (6) 64.8 ± 2.7 (6) 
Depolarization  
by 15 mM glucose  
(% maximal effect) 
69.5 ± 1.2 (6) 67.8 ± 1.9 (6) 71.7 ± 2.6 (6) 
Depolarization  
by 100 µM ATP  
(% maximal effect) 
72.3 ± 1.5 (6) 72.8 ± 1.8 (6) 73.5 ± 1.6 (6) 
Depolarization  
by 23 mM KCl  
(% maximal effect) 
86.4 ± 1.3 (6) 85.7 ± 1.9 (6) 88.5 ± 1.8 (6) 
Basal [Ca2+]i  (nM) 108 ± 9 (3) 98 ± 7 (3) N.D. 
[Ca2+]i increase  
by 23 mM glucose (nM) 
178 ± 21 (3) 175 ± 13 (3) N.D. 
[Ca2+]i increase  
by 40 mM KCl (nM) 
309 ± 11 (3) 318 ± 21 (3) N.D. 
Formazan production from MTS test was measured over 30-min incubation. Maximal 
membrane depolarization was achieved with a saturating concentration of KCl (40 mM). The 
indicated conditions of KCl stimulation are the final concentrations of K+ in the incubation 
medium. The numbers of experiments are indicated in the parentheses. N.D., not determined. 
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3.11  Stable expression of dominant negative Rac1 inhibits mastoparan-
induced insulin secretion 
To further confirm that Rac is an important regulatory protein in insulin secretion, 
mastoparan-stimulated insulin secretion was also studied in INS-1 cells stably 
expressing vector alone or the dominant inhibitory Rac1. Mastoparan is a potent 
activator of G-proteins, in particular for trimeric G proteins. The data showed in Fig. 
3.16 demonstrated that mastoparan (30 µM for 45 min) markedly stimulated insulin 
secretion. Furthermore, a significant reduction (by ~30%) in mastoparan-induced 
insulin secretion was observed in INS-1 cells expressing N17Rac (Fig. 3.16). The 
results indicated that Rac represents one of the regulatory proteins involved in 












































Fig. 3.16. Stable expression of dominant 
negative form of Rac markedly attenuates 
mastoparan-induced insulin secretion from 
INS-1 cells  INS-1 cells (control or transfected 
with dominant inhibitory Rac1) in 24 well-plates 
were preincubated in KRBH (with 2.8 mM 
glucose) buffer for 30 min.  Then the cells were 
stimulated by 30 µM mastoparan for 45 min. 
Results are mean ± SE of three separate 
experiments in triplicate. ** P<0.05 vs. control. 
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Part II  Expression of syncollin affects regulated insulin secretion in  
INS-1 cells 
3.12 Background  
Studies on the isolated pancreatic β-cells and established β-cell lines have been 
extensively carried out to define the underlying mechanism of the regulated 
exocytosis, which also takes place in exocrine cells, neuronal cells and white blood 
cells as well. SNARE proteins were originally identified as synaptic proteins but now 
it is understood that they are universally involved as the core machinery in all 
intracellular fusion events (Jahn and Sudhof, 1999). It is well known that exocytosis 
involves these molecules, which are expressed in the above exocytotic cell systems. 
Consequently, the same mechanism of action of SNARE proteins might be shared in 
all exocytotic cells. In pancreatic β cells, the v-SNAREs [synaptobrevin (VAMP-2), 
cellubrevin] and synaptotagmin III are expressed in the secretory granules, whereas the 
t-SNAREs (syntaxin 1, 2, 3 and SNAP-25) are located on the plasma membrane 
(Hansen et al., 1999). These SNARE proteins are required for Ca2+-triggered 
exocytosis of insulin granules since their destruction by proteolysis with specific 
bacteria toxins abolishes this process (Huang et al., 1998; Lollike et al., 2002; Regazzi 
et al., 1996b; Wheeler et al., 1996). However, the complete machinery and, in 
particular, the regulation of this process are still far from clear. 
Syncollin was initially identified as a syntaxin-binding protein in pancreatic exocrine 
acinar cells (Edwardson et al., 1997). Introduction of this protein in an in vitro 
exocytosis system affected the fusion of isolated secretory granules with the plasma 
membranes, an effect mediated by its interaction with syntaxin in a Ca2+-dependent 
manner (Edwardson et al., 1997). However, subsequent work found that endogenous 
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syncollin in exocrine pancreatic acinar cells seems to be a luminal protein in secretory 
granules and its physiological function remains ambiguous (An et al., 2000). 
Expression of this protein is also observed in small intestine and parotid gland 
(Edwardson et al., 1997; Imai et al., 2001; Tan and Hooi, 2000). Interestingly, its 
expression in small intestine is up-regulated by feeding (Tan and Hooi, 2000), 
suggesting a potential role in the regulation of secretion of digestion enzymes.  
The gene for syncollin isolated from rat expresses a protein of 134 amino acids in full 
length with a hydrophobic domain at its N-terminal (An et al., 2000; Tan and Hooi, 
2000) (Fig.3.17), a common feature of SNARE proteins. On the other hand, the 
sequence of this hydrophobic domain also meets the criteria as a signal peptide and 
thus might function to direct the protein into ER lumen to form secretory proteins and 
ER chaperons. A truncated form of syncollin lack of this domain may result in 
inappropriately intracellular localization and loss of its normal function.   
The findings of potential role of syncollin in exocytotic process in vitro and the failure 
to identify its expression (but cannot rule out the existence of an isoform) in pancreatic 
β cells, promoted present study to determine the possible role of syncollin in regulated                       
secretion in vivo by using intact INS-1 cells as a model, at the time when the first study 
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 5’ 
 1 GTCCATTGTCACC ATG  TCC  CCG  CTG  TGC  CTG  CTG  TTG  CTG  GCT 
 1                   Met    Ser      Pro   Leu    Cys    Leu    Leu   Leu    Leu    Ala
 44 TTA  GCC  CTG  GTG  GCT  GTC  CCC  GGT  GCC  CGA  GGC  GCT  TGT  CCA  
 11 Leu     Ala    Leu    Val     Ala     Val     Pro    Gly    Ala     Arg     Gly    Ala     Cys     Pro 
 86 GTG  CCC  GCA  GAC  CTG  AAG  AAG  TCA  GAT  GGG  ACG  CGC  ACG  TGC  
 25  Val     Pro     Ala      Asp    Leu     Lys     Lys    Ser     Asp    Gly   Thr    Arg      Thr    Cys 
 128 GCC  AGG  CTC  TAT  GAG  AAC  AGT  GAC  CCC  TAC  TAT  GAC  AAC  TGC  
  39 Ala     Arg   Leu    Tyr   Glu    Asn   Ser     Asp    Pro  Tyr   Tyr   Asp    Asn   Cys 
  170 TGC  CAG  GGG  CCT GAA  CTG  TCT  GTG  GAT  CCA  GGC  ACC  GAC  CTG  
    53 Cys    Gln    Gly    Pro    Glu    Leu   Ser    Val    Asp   Pro   Gly    Thr    Asp    Leu 
   212 CCC  TAC  CTG  CCC  TCG  GAC  TGG TCT  AAC  TCG  GCA  TCT  TCT  CTG  
     67 Pro    Tyr    Leu    Pro   Ser    Asp    Trp   Ser    Asn    Ser    Ala    Ser    Ser    Leu 
  254 GTA  GTG  GCC  CAG  CGC  TGC  GAG  CTC  ACC  GTG  TGG  TCT  CTC  CCT  
    81 Val     Val    Ala    Gln    Arg   Cys    Glu   Leu    Thr    Val    Trp   Ser    Leu    Pro 
   296 GGT  AAA  CGT  GGC  AAG  ACA  CGC  AAG  TTC  TCT  ACG  GGT  AGC  TAC  
    95 Gly     Lys    Arg    Gly    Lys   Thr    Arg    Lys    Phe    Ser   Thr    Gly     Ser   Tyr 
    338 CCT  CGA  CTG  GAA  GAG  TAC  CGC  AAA  GGC  ATC  TTT  GGA  ACC  TGG  
    109 Pro     Arg    Leu    Glu    Glu    Tyr    Arg    Lys     Gly    Ile     Phe    Gly     Thr    Trp  
   350 GCC  AAG  TCC  ATC  TCT  GGC  CTC  TAC  TGC  AAG  TGC  TAT  TGA  TGT  
   123 Ala     Lys    Ser     Ile    Ser    Gly   Leu    Tyr    Cys     Lys    Cys    Tyr    *** 
    422 CTTGAGGGTCTGTCGTCTCTGATTCTGCACAGTGCTGAGCCTTACCCAGTCTGTCC  
 
    478 TTGGGGATTGCTCTGACCCCAAGAGCCAGGAGGCAAGATGGCCCCATTACCTGCTA 
     534 TCAGAGCTTCCCTATAATACAGCCCTGGTGTAAGCTAAAAAAAAAAAAAAAAAAAAA  3’ 
 
Fig. 3.17  DNA and amono acid sequence of rat syncollin. N-termianl 19 amino acids 
were deleted in truncated syncollin construct. Myc-tagged constructs was derived by 
omitting the terminal code TGA when clone the gene into pcDNA/Myc-His vector to get 
c-Myc tag at C-terminal. 
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3.13 Syncollin and truncated syncollin display different distribution in 
subcellular fractions after expressed in INS-1 cells  
Syncollin was not expressed in both control INS-1 cell and HIT-T15 cells (Fig. 3.18), 
as assessed by Western blotting using antiserum against a 16-residue peptide (residues 
96-108) of rat syncollin, as well as by RT-PCR by using syncollin N-terminal 
sequence 5’-accatgtccccgctgtgcct-3’ and C-terminal sequence 5’-tcaatagcacttgcagtaga-
3’ as forward and reverse primers.  
After INS-1 cells were stably transfected with the two syncollin constructs through 
antibiotics (geneticin) selection and verified by western blotting (Fig. 3.18B) and 
immunofluroscence staining (Fig. 3.19), the polyclonal cell population obtained was 
used for further studies. In INS-1 cells transfected with syncollin or its truncated form 
(lacking of N-terminal hydrophobic domain), both cells expressed a protein of 
approximate 16 kD of molecular mass (Fig. 3.18B, lane 1 and 2).  
In this transfected INS-1 β-cell system, both syncollin and its truncated form were 
found exclusively associated with the membrane-contained subcellular fractions when 
assessed by Western blotting (Fig. 3.20). In full-length syncollin transfected INS-1 
cells, strong signals were detected in the fractions rich of secretory granules or 
mitochondria and in the plasma membrane, while a weak signal was observed in 
microsomes (Fig. 3.20). However, in cells transfected with the truncated syncollin, a 
strong signal was detected in microsomes, a weak signal in fractions rich of 
mitochondria or secretory granule, but no signal in the plasma membrane. 
Consequently, syncollin is mainly localized in granule- and mitochondria-enriched 
fractions as well in the plasma membrane, whereas transfection of the truncated 
syncollin produces a protein predominantly distributed in microsomes (Fig. 3.20). 
These results suggest that the N-terminal hydrophobic domain of syncollin may play 
an important role in directing the expressed syncollin to the intracellular destinations.  
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Fig. 3.18 Detection of syncollin expression in insulin secretion cell lines. A. RT-PCR assay of 
syncollin expression in cell lines and trasnfected cells. Lane1, pcDNA/Myc-His vector tranfected INS-1 
cells; lane 2, syncollin transfected INS-1 cells; lane 3, truncated syncollin transfected INS-1 cells; lane 
4, INS-1 cells; lane 5, pancreatic acinar cell line AR42J cells as positive control; lane 6, Insulin-
secreting HIT-T15 cells. GAPDH was used as internal control. B. Western blotting assay of syncollin 
expression. Lane 1, syncollin transfected INS-1 cells; lane 2, truncated syncollin transfected INS-1 cells; 
lane 3, INS-1 cells; lane 4, AR42J cells; lane 5, HIT-T15 cells. β-actin was used as internal control. 
 
 
Fig. 3.19. Identification of expressed syncolln constructs in INS-1 cells. Expression of syncollin and 
truncated syncollin in INS-1 cells was verified by immunofluorescence staining with anti-syncollin 
antiserum and TRITC-conjugated anti-rabbit IgG. Images were detected by Olympus IX70 Fluoroview 
300 laser confocal microscopy. Bar=50µm. 
 
 Fig. 3.20.  Subcellular localization of expressed 
syncollin in INS-1 cells by immunoblotting 
detection. Cells were homogenized and separated by 
differential centrifugation to obtain cytosol (Cyt), 
mitochondria-rich (Mt), insulin granule-rich (SG), 
microsomal (MS), and plasmalemma-rich (PM) 
fractions. Equal amounts (20 µg) of proteins from each 
fraction was separated by SDS-PAGE and probed by 
an anti-syncollin anti-serum. Data are the 





Cyt SG     Ms    Mt    PM
16KD
β-actin
1     2     3     4     5
GAPDH






 Chapter 3 Results  
 - 73 - 
3.14 Syncollin is co-localized with insulin secretory granules, but not ER, 
Golgi apparatus and mitochondria in INS-1 cells 
The subcellular fractionation methods used in this study produce only organelle-
enriched, but not sole, subcellular organelle fractions, since analysis of organelle 
markers in these fractions indicated a cross-contamination between them to various 
extents (Li et al., 1996). Thus double immunofluorescence staining was also 
performed in order to better define the intracellular localization of expressed syncollin. 
The results revealed that, in cells transfected with full-length c-Myc-tagged syncollin, 
the expressed protein was not co-localized with the markers of ER (calnexin; Fig. 
3.21A-C), Golgi apparatus (α-mannosidase II; Fig. 3.21D-F), or mitochondria 
(MnSOD; Fig.  3.21 G-I). The only co-localized fluorescence signal with syncollin is 
insulin, which is the marker of secretory granules (Fig. 3.21J-L). As to truncated 
syncollin, it was found co-localized with the marker of Golgi apparatus (α-
mannosidase II; Fig. 3.22D-F), and partly with the marker of ER (calnexin; Fig. 3.22 
A-C), but not with the markers of mitochondria (MnSOD; Fig. 3.22 G-I) and secretory 
granules (Fig. 3.22 J-L). The observed syncollin signal in mitochondria-enriched 
fraction above by Western blotting could come from contaminated insulin granules, 
since analyses of the organelle markers in this fraction obtained by differential 
centrifugation indicated that it contains moderate insulin content (Li et al., 1996). All 
these observations indicate that transfected syncollin in INS-1 cells is specifically 
expressed in secretory granules and this process is dependent on the N-terminal 
hydrophobic domain. 
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Fig. 3.21. Intracellular co-localization of expressed syncollin in INS-1 cells. Transient 
expression (2 days) of c-Myc-tagged syncollin in INS-1 cells was examined by immunofluorescence 
staining with anti-c-Myc monoclonal antibody and TRITC-conjugated anti-mouse IgG (B, E, H) or anti-
c-Myc polyclonal antibody and FITC-conjugated anti-rabbit IgG (K). ER was detected by anti-Calnexin 
polyclonal antibody and FITC-conjugated anti-rabbit IgG (A). Golgi apparatus was detected by anti-α-
mannosidase II antiserum and FITC-conjugated anti-rabbit IgG (D). Mitochondria were detected by 
anti-MnSOD polyclonal antibody and FITC-conjugated anti-rabbit IgG (G). Secretory granules were 
detected by anti-insulin monoclonal antibody and TRITC-conjugated anti-mouse IgG (J). Images were 
detected by laser confocal microscopy. Data are the representative of at least 3 experiments with 
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Fig. 3.22.  Intracellular co-localization of truncated syncollin in INS-1 cells. Transient expression (2 
days) of c-Myc tagged truncated syncollin in INS-1 cells was examined by immunofluorescence 
staining with anti-c-Myc monoclonal antibody and TRITC-conjugated anti-mouse IgG (B, E, H) or anti-
c-Myc polyclonal antibody and FITC-conjugated anti-rabbit IgG (K). ER was detected by anti-Calnexin 
polyclonal antibody and FITC-conjugated anti-rabbit IgG (A). Golgi apparatus was detected by anti-α-
mannosidase II antiserum and FITC-conjugated anti-rabbit IgG (D). Mitochondria were detected by 
anti-MnSOD polyclonal antibody and FITC-conjugated anti-rabbit IgG (G). Secretory granules were 
detected by anti-insulin monoclonal antibody and TRITC-conjugated anti-mouse IgG (J). Data are the 
representative of at least 3 experiments with identical results. Images were detected by laser confocal 
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3.15 Insulin release simulated by secretagogues is reduced in INS-1 cells 
transfected with syncollin but not in cells with its truncated form  
Although syncollin in transfected INS-1 cells seems to be localized in secretory 
granules, the insulin content of INS-1 cells was not altered by stably expressing either 
syncollin or its truncated form lacking the N-terminal hydrophobic domain (0.41 ± 
0.03, 0.42 ± 0.03, and 0.43 ± 0.04 ng /ng DNA, respectively). Moreover, the basal 
insulin secretion in these cells was also not affected (see the values in Fig. 3.23 
legend). However, in full-length syncollin transfected cells, insulin secretion 
stimulated by 15 mM glucose alone or combined with 1 µM forskolin (which raises 
cAMP by directly stimulating adenylyl cyclase) was significantly decreased by 47% 
and 55%, respectively (Fig. 3.23). High potassium (34 mM)-elicited insulin release 
(through promoting membrane depolarization and Ca2+ entry) was also significantly 
inhibited by 47% in these cells. By contrast, transfection of INS-cells with the 
truncated syncollin did not alter the insulin secretory responses to the same stimulants 
above (Fig. 3.23). These results suggest that expression of syncollin in the secretory 
granules of β-cells impairs insulin secretion upon stimulation, possibly at step(s) as 
late as Ca2+ mobilization or effects.  
 Fig. 3.23.  Inhibition of secretagogue-induced 
insulin secretion in INS-1 cells after 
transfection of full-length but not truncated 
syncollin. Cells were cultured in 24-well plates. 
After stimulation of cells by secretagogues for 30 
min, insulin secretion and insulin content were 
measured by RIA. Basal secretion rates are 2.23 ± 
0.19, 2.17 ± 0.21 and 2.82 ± 0.38 (% of content) in 
control, syncollin-transfected, and truncated 
syncollin-transfected cells, respectively. Data are 
mean ± SEM from 4 independent experiments in 
triplicates. Concentrations used: 15 mM glucose, 1 
µM forskolin, 34 mM KC1. ** P<0.01 vs. control. 
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3.16 No effect of syncollin expression on membrane depolarization and 
[Ca2+]i elevation 
Since the expression of syncollin in INS-1 cells produced a general inhibition on 
stimulated insulin secretion, the possible alterations in the generation of proximal 
signals for the stimulus-secretion coupling were examined. The results indicated that 
glucose-induced membrane depolarization was not altered in INS-1 cells transfected 
with syncollin (data not shown). Moreover, the [Ca2+]i elevations evoked by glucose 
(15 mM) or high K+ (34 mM) were also not reduced in these cells, although the [Ca2+]i 
elevations by high K+ were slightly (~20%) but significantly higher in the cells 
transfected by either forms of syncollin (Fig. 3.24). Together these data suggest that 
syncollin may inhibit insulin at late steps in the exocytotic cascade. 
 Fig. 3.24.  Glucose and high K+-evoked 
[Ca2+]i rises were not reduced in syncollin-
expressed INS-1 cells. [Ca2+]i levels in INS-1 
cells were measured by loading a fluorescent 
Ca2+ probe (fura-2) as described in detail in the 
Methods section. Values are mean ± SEM from 
3 independent experiments. Concentrations 
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Chapter 4       
Discussion 
4.1 The role of Rac1 in regulated insulin secretion 
4.1.1 Activation of Rac1 by glucose stimulation in insulin-secreting cells 
Earlier studies (Kowluru et al., 1997b; Daniel et al., 2002; Kowluru et al., 2003) have 
provided indirect evidence for the involvement of Rho subfamily of GTP-binding 
proteins in physiological insulin secretion. For example, by inhibition of requisite post-
translational modifications (i.e., farnesylation, carboxyl methylation, and fatty 
acylation), it has been shown that blockade of these modifications resulted in a marked 
reduction of glucose-stimulated insulin secretion from normal rat islets and clonal β 
cell preparations (Amin et al., 2002; Cheng et al., 2003; Kowluru et al., 1997a). 
Furthermore, Clostridial toxins (e.g., toxin B and lethal toxin), which selectively 
glucosylate and inactivate Rho subfamily GTP-binding proteins (Aktories et al., 2000), 
have been shown to inhibit glucose-stimulated insulin secretion from normal rat islets 
and clonal beta cells (Kowluru et al., 1997b). In addition, it has been demonstrated  
that under conditions of stimulated insulin secretion, glucose augmented the carboxyl 
methylation and membrane-association of Rho family of GTP-binding proteins, 
including Cdc42 (Kowluru et al., 1997a). Taken together, these findings suggested 
involvement of Rho GTPases in insulin secretion. Observations in the current study 
provided the first direct evidence with regard to the identity of one of these GTP-
binding proteins as Rac1, since the expression of a dominant inhibitory form of Rac1 
resulted in marked reduction in glucose- and cAMP-mediated insulin secretion from 
INS-1 cells. This action occurred without apparently affecting the secretory response 
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to elevated [Ca2+]i per se, suggesting that the very distal steps in secretory machinery 
remain largely intact. The disappearance of F-actin filaments in these cells indicated 
that F-actin fibers may be necessary for the recruitment of secretory granules to the 
plasma membrane for exocytosis.  
The primary objective of this study was to examine the putative regulatory roles for 
Rac1, a small GTP-binding protein, in physiologic insulin secretion from insulin-
secreting INS-1 cells. The data revealed, for the first time, that physiological 
concentration of glucose was able to cause Rac1 translocation from the soluble to the 
membranous fraction, an indication of Rac1 activation. Interestingly, such a glucose-
induced translocation of Rac1 could be found only after 15 min stimulation. In 
addition, direct evidence for Rac1 activation by glucose was demonstrated by 
measuring the amount of activated, GTP-bound form of the G-protein using a pull-
down assay with a GST-PAK-CD as a probe. Although elevating cAMP by forskolin 
can markedly potentiate glucose-stimulated insulin release, inclusion of forskolin did 
not enhance glucose-induced Rac1 translocation. Translocation of Rac1 to membranes 
occurred in other cell systems upon stimulation. A typical example is that in 
neutrophils stimulated by fMLP or PMA, the cytosolic Rac1 and Rac2 were 
translocated to cell membranes, a process required for the activation of NADPH 
oxidase (Dusi et al., 1996). Similar observations were also reported in angiotensin II-
stimulated cardiomyocytes and vascular smooth muscle cells (Laufs et al., 2002; 
Wassmann et al., 2001), in serum-activated MDCK cells (Hansen and Nelson, 2001), 
and in platelet-derived growth factor stimulated Swiss 3T3 fibroblasts (Fleming et al., 
1996). 
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4.1.2  Altered intracellular distribution of Rac1 mutants and possible 
relationship with their function 
The dominant inhibitory N17Rac1 and constitutively active V12Rac1 are the two Rac 
mutants most widely used to study the Rac1 function. These two mutants work by  
different mechanisms on activating and inactivating of Rac1 (Feig, 1999; Ridley, 
2000). It is believed that N17Rac1 interferes with the activation of its normal 
counterpart by competing with the binding to guanine nucleotide exchange factors 
(GEFs) and thus blocking the functions of endogenous Rac1 (Feig, 1999). In addition, 
this mutant may not interact with Rac effectors because of a reduction in its affinity to 
bind to Mg2+ which is required for GTPases to reach an active conformation (Feig, 
1999). It should be noted that N17Rac1 may also interfere with the functions of other 
Rho family proteins if these GTPases are activated by the same GEFs.  
On the other hand, a mutation of Rac1 at Gly12 (to Val12) decreases its intrinsic and 
GAP-stimulated GTPase activity, allowing proteins to remain predominantly in the 
GTP-bound, active form (Ridley, 2000). The mechanisms for the effects of V12Rac1 
on cellular functions are less clear and complex. This constitutively active GTPase 
mutant may directly activate certain Rac1-mediated pathways through interaction with 
the effectors. However, this active Rac1 mutant presumably may also block the 
interaction of endogenous Rac1 with downstream targets, since it has been proposed 
that this mutant can bind to and trap Rac1 effector proteins in the cytosol and prevent 
their association with target membranes (Feig, 1999). Therefore, the efficiency of this 
mutant to suppress Rac1 functions would be minimal, whereas its ability to trigger 
some Rac1-mediated events may be dominant.  
Like other Rho proteins, the activity of Rac GTPases depends on their binding to GTP 
or GDP, which may also govern their intracellular distribution. Thus Rac1 is found in 
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both cytoplasm and membranes in normal cells (Kraynov et al., 2000; Kumanogoh et 
al., 2001; Michaelson et al., 2001). In the current study using INS-1 cells, endogenous 
Rac1 was found mostly localized in cytosol fraction. By contrast, the dominant 
inhibitory Rac1 mutant was only distributed in the membrane associated fractions 
enriched in secretory granules and mitochondria. Dominant inhibitory Rac1 could be 
postulated primarily associated with secretory granules, since the mitochondria-
enriched fraction obtained in this study by differential centrifugation may be 
contaminated by the granules (Li et al., 1996). The constitutively active Rac1 mutant 
was distributed in cytosol and also all other isolated membrane-containing fractions. 
The observation that dominant inhibitory Rac1 mutants were predominantly 
distributed in the membranes seems to belie the notion that, when activated, GTPases 
would be associated with the target membranes. However, it has been found that 
mutations that render RhoA, CDC42hs, or Rac1, either constitutively active or 
dominant inhibitory, abrogated their binding to RhoGDI and redirected them to both 
plasma and internal membranes in liver cells (Michaelson et al., 2001), which could 
explain the findings in the present study.  
An important observation in this study is that glucose stimulation is able to cause 
translocation of Rac1 from cytosol to membranes, including plasmalemma, in control 
INS-1 cells. However, the distribution patterns of either dominant inhibitory or -active 
Rac1 mutants in transfected cells were not changed when stimulated by secretagogues. 
Importantly, glucose was no longer able to induce endogenous Rac1 translocation in 
cells expressing either Rac1 mutants. This failure appears not to be due to the 
impairment of glucose metabolism and other early steps in stimulus-secretion coupling 
(e.g. membrane depolarization and elevation of [Ca2+]i), rather it seems more likely 
due to the interference with endogenous Rac1 by the mutants directly. In addition, 
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expression of N17Rac1 was also not apparently affecting the secretory response to 
elevated [Ca2+]i per se, suggesting that the very distal steps in secretory machinery 
remain largely intact. The inhibitory effects of N17Rac1 could be mediated by two 
modes: preventing the activation of endogenous Rac1 by competitive binding to GEFs 
(Feig, 1999) and occupying the target sites of Rac1 on the membranes because of its 
dominant distribution in the membranes.  
Interestingly, expression of V12Rac1 did not enhance basal and stimulated insulin 
secretion. This is in contrast to the observations in other cells such as mast cells and 
chromaffin cells, where introduction of constitutively active Rac evoked secretion 
(Brown et al., 1998; Gasman et al., 1999; Price et al., 1995). Present data suggested 
that activation of Rac1 may be necessary but not sufficient for the maintenance of 
stimulated insulin secretion. This notion is also supported by the observation that 
expression of wild-type Rac1 did not affect both cell morphology (data not shown) and 
secretory responses. 
The non-specific effects due to overexpression of a protein in transfection experiments 
should be considered. There is evidence that such an effect was minimal in this study. 
No overexpression was found in stable transfected cells, since the total amount of 
Rac1 (endogenous plus mutant) from cell lysate of either Rac1 mutant-transfected cells 
was not significant different from that of control cells. Only small amount of mutant 
proteins was found in contrast to endogenous Rac1. And marked alterations of insulin 
secretory response, cell morphology and F-actin cytoskeleton were only observed in 
cells transfected with N17Rac1, but not V12Rac1, suggesting a specific effect of the 
former. Furthermore, stable expression of wild type Rac1 had no effect on morphology 
and secretagogues-induced insulin release in INS-1 cells. 
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4.1.3 Involvement of Rac1 mainly in the late phase of insulin secretion  
It is well known that glucose induces biphasic insulin secretion (Bratanova-Tochkova 
et al., 2002; Henquin et al., 2002; Rorsman et al., 2000). Accumulating evidence 
favorsthe two-compartmental model (Bratanova-Tochkova et al., 2002; Rorsman et al., 
2000), in which the second phase of secretion requires the promotion/recruitment of 
secretory granules to the exocytotic sites, although the details of underlying 
mechanisms remain to be defined. Current studies revealed that only the late phase of 
glucose-stimulated insulin secretion was significantly reduced in N17Rac1-transfected 
INS-1 cells. Moreover, although both phases of insulin secretion induced by forskolin 
plus glucose were attenuated in these cells, a larger inhibitory effect occurred during 
the late phase. These results suggest that Rac1 may play a major role in the late phase 
of glucose-stimulated insulin secretion. That fact that glucose only significantly 
increased Rac1 translocation to membranes at 15 min also supports this notion. The 
inhibitory effect on insulin secretion by N17Rac1 might be attributable to the 
interference with glucose-induced activation of endogenous Rac1 as discussed above.  
Although an involvement of Rac proteins in the Ca2+-dependent exocytosis has been 
reported in neuronal cells (Doussau et al., 2000; Komuro et al., 1996), expression of 
the inactive Rac1 mutant did not significantly affect the insulin secretion stimulated by 
Ca2+ per se (through high K+ depolarization) in INS-1 cells. Thus it seems that Rac1 
did not engage in the very distal step of exocytosis in INS-1 cells. In addition, the 
preferred inhibition of the late phase secretion by the expression of N17Rac1 may also 
explain its failure to significantly inhibit insulin secretion induced by high K+, since 
only a monophasic insulin release (equivalent to the early phase) was evoked under 
this stimulatory condition (Sato et al., 1992).  
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4.1.4  Actin cytoskeleton reorganization may contribute to Rac1 effects on the 
maintenance of morphology and regulation of insulin secretion in β-cells 
There is strong evidence that Rac is a key control element in the reorganization of 
actin cytoskeleton (Hall, 1998). Microinjection of V12Rac was capable of inducing 
lamellipodia and membrane ruffle as well as subsequent stress fiber formation, 
whereas injection of N17Rac prior to the addition of growth factors or together with 
V12Rac abolished these effects in fibroblasts (Ridley et al., 1992).  Thus it is not 
surprising that the morphology of β-cells would be altered by interference with Rac 
function. The morphological changes in Rac1 mutants-transfected cells were 
accompanied with the alterations in the F-actin distribution. F-actin filaments almost 
completely disappeared in N17Rac1-transfected cells as assessed by phalloidin 
staining and these cells were rounding-up. Surprisingly, expression of constitutively 
active Rac1 mutant did not enhance the formation of actin cytoskeleton as in other cell 
types (Ridley et al., 1992), rather had small opposite effect. Importantly, F-actin 
structure may be not only for the maintenance of INS-1 cell morphology but also 
involved in the transport of secretory granules, since loss of these F-actin filaments in 
N17Rac1-transfected cells displayed preferred inhibition of the late phase of 
stimulated insulin secretion. Previous study using Clostridium botulinum C2 toxin to 
disrupt F-actin structure also found a more severe inhibition of the second phase of 
insulin secretion in HIT-T15 cells and in isolated pancreatic islets (Li et al., 1994). 
Together, these findings suggested that the role of Rac1 in regulated insulin secretion 
may involve the regulation of actin cytoskeleton reorganization for secretory granule 
recruitment which is required for the second phase of secretion (Howell and Tyhurst, 
1986; Li et al., 1994). 
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4.1.5 Rac may be involved in cAMP potentiated insulin secretion  
It is well known that protein kinase A (PKA) activation by cAMP can positively 
influence regulated secretion in many cell systems including β-cells. It has been 
reported that PKA can regulate Rac1-dependent organization of actin cytoskeleton 
during the migration of carcinoma cells (O'Connor and Mercurio, 2001). It is thus 
likely that Rac1 inactivation may affect the PKA-mediated potentiation of insulin 
secretion through disruption of actin cytoskeleton organization in INS-1 cells. Indeed 
the late phase of forskolin-potentiated insulin secretion was more heavily inhibited in 
N17Rac1 transfected cells, suggesting that forskolin-activated PKA may be important 
for the trafficking of secretory granules in β-cells (Hisatomi et al., 1996; Renstrom et 
al., 1997). On the other hand, forskolin may also potentiate insulin secretion by PKA-
independent mechanism through cAMP-GEFII which interacts with Rap1 (belong to 
Ras family) and Rim proteins (Rab3-interacting molecules) (Ozaki et al., 2000; 
Renstrom et al., 1997), indicating the existence of a cross-talking between cAMP and 
small G-proteins. Whether cAMP is able to activate GEFs for Rho family proteins 
or/and interact with them remains to be defined, though a clear effect of forskolin on 
Rac1 translocation in INS-1 cells could not be detected in the present study. 
4.1.6 Role of Rac1 in mastoparan-induced insulin secretion from β-cells   
Mastoparan is capable to stimulate insulin secretion by activating G-proteins, 
presumably via activation of trimeric G proteins. However, there is also evidence from 
collaborated work for the implication of Rac in this scenario by using Clostridium 
toxins to inactivate certain members of Rho proteins (Amin et al., 2003). Mastoparan-
induced insulin secretion was attenuated in INS-1 cells expressing the dominant 
inhibitory Rac1 mutant, though less extent than the glucose and forskolin-stimulated 
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secretion, suggesting the involvement of other molecules. Mastoparan is able to 
activate Rac1 in β-cells, as demonstrated by direct measurement of active Rac1 and 
translocation of Rac1 (also Cdc42 to a less extent) from cytosol to insulin-containing 
granules (Amin et al., 2003). Interestingly, mastoparan-induced GTP/GDP exchange 
of Rac did not require post-translational modification of C-terminal cysteins (Ohara-
Imaizumi et al., 2001), which was essential for glucose-induced insulin secretion 
(Amin et al., 2003). In addition, expression of wild type Cdc42 increased mastoparan-
induced insulin secretion in an insulin-secreting cell line (βHC9) (Daniel et al., 2002), 
suggesting other Rho family proteins may be also involved in mastoparan stimulated 
insulin release. Therefore, it is likely that Rac/Cdc2 translocation to insulin granule is 
essential for mastoparan-induced insulin release (Amin et al., 2003; Daniel et al., 
2002). Whether Cdc42 is involved in glucose-stimulated insulin secretion remains to 
be investigated. 
4.1.7 PIP5K may play a role downstream of Rac1 in regulated insulin secretion 
Phosphatidylinositol-4 phosphate 5 kinase (PIP5K) is a key enzyme catalyzing the 
synthesis of phosphatidylinositol-4,5-bisphosphates [PtdIns(4,5)P2] and a potential 
effector of Rac1. PtdIns(4,5)P2 is important for signal transduction, cytoskeletal and 
membrane trafficking events (Martin, 1998). A decrease in PtdIns(4,5)P2 levels caused 
inhibition of exocytosis in neuroendocrine cells, suggesting that PtdIns(4,5)P2 
synthesis can influence exocytosis either by interacting with SNARE proteins directly 
or by anchoring ADP-ribosylation factor and GAPs to the fusion site of membrane 
(Martin, 1998). There are several PIP5K isoforms, including the 68-kDa type I 
(PIP5KIα and PIP5KIβ) and 53-kDa type II (PIP5KII). PIP5KIs have wide tissue 
distributions, but their expression levels differed greatly. PIP5KIs are stimulated by 
phosphatidic acid and possibly regulated by Rac G-proteins since they could directly 
 Chapter 4 Discussion  
 - 89 - 
associate with Rac1 but not Rho and Cdc42 (Tolias et al., 2000). GTPγS has been 
found to increase PIP5K activity in many tissues and cells (Stephens et al., 1993). Rac 
activation causes an increased synthesis of PtdIns(4,5)P2, which may be mediated by 
Rac stimulation of a PIP5KIs (Chatah and Abrams, 2001). The downstream proteins in 
this scenario are gelsolin and other capping proteins whose actin barbed-end capping 
activities are inhibited by phosphoinositides. In platelets, Rac activation results in 
increased actin polymerization for lamellae formation, which arises from an increase 
in the number of free actin barbed-ends available for filament elongation due to 
PtdIns(4,5)P2 binding to cap proteins (Tolias et al., 2000). Thus PIP5KIs may function 
as an effector of Rac in mediating the reorganization of actin cytoskeleton.  
It is interesting that PIP5K can associate with both GTP- and GDP-Rac either in vitro 
or in vivo (Martin, 1998; Tolias et al., 2000). PIP5K binds to the C-terminus of Rac 
and this interaction is augmented in the presence of specific phospholipids (Carpenter 
et al., 1999). Since PIP5K activity is not affected by Rac per se (Chong et al., 1994), 
the effect of Rac1 on exocytosis by regulating PIP5K is most probably achieved by 
promoting its translocation. It seems that PIP5KI, not PIP5KII, mediates Rac-
dependent actin assembly and is required for secretion (Tolias et al., 2000). The results 
from current study revealed that incubation with 15 mM glucose significantly 
increased translocation of PIP5KIα (~60 kD) from cytosol to the membranes in INS-1 
cells and such an effect was not demonstrable when the cells were transfected by a 
dominant inhibitory Rac1 mutant. These results are very similar to those with Rac1, 
suggesting the increased PIP5KIα translocation to membranes is possible due to its 
binding with Rac1. Thus a close relationship between the two proteins and their 
association with insulin secretion may exist in β-cells. The interference with PIP5KIα 
translocation to the membrane might contribute to the observed disruption of actin 
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cytoskeleton and inhibition of insulin secretion in the N17Rac1-transfected INS-1 
cells, since this may decrease the local concentrations of PtdIns(4,5)P2, which is 
required for ATP-dependent priming in neuroendocrine cells (Martin, 1998).  
In conclusion, glucose stimulation increased Rac1 activity and led to its translocation 
from cytosol to the membranes in INS-1 cells. Expression of dominant inhibitory Rac1 
abolished such effect. This study also provided direct evidence for a role of Rac1 in 
the regulation of insulin secretion, as demonstrated by the clear inhibition of glucose- 
and forskolin-induced insulin secretion in INS-1 cells expressing negative Rac1. Such 
inhibitory effect was mainly on the late phase of glucose and forskolin stimulated 
insulin secretion. The disappearance of F-actin filaments in these cells indicated that 
these F-actin fibers may be necessary for the recruitment of secretory granules to the 
plasma membrane for exocytosis. This action was not associated with an impairment 
of generating proximal signals required for glucose-evoked secretion. It seems that 
Rac1 is not involved in the very distal steps in secretory event, since the secretory 
response to elevated [Ca2+]i per se was affected in N17Rac-transfected cells. In 
addition, mastoparan (which activates Rac1)-induced insulin secretion was also 
inhibited in INS-1 cells expressing N17Rac1. It is possible that PIP5KIα, which is 
implicated in actin cytoskeletal organization and secretory event, may be an effector of 
Rac1 participating in glucose-induced insulin secretion. 
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4.2 Intracellular targeting of syncollin and its possible role in regulated 
secretion 
4.2.1 Expressed syncollin is associated with membranes in INS-1 cells  
In current study, syncollin and its truncated form (lack of signal peptide) were stably 
expressed in a widely used insulin-secreting β-cell (INS-1) line. The expressed 
products from transfection of both syncollin and its truncated form were membrane-
associated, when assessed by subcellular fractionation followed by Western blotting. 
These observations seem puzzling at glance, since the truncated syncollin does not 
contain a membrane-associated domain. Moreover, the N-terminal hydrophobic 
domain in the full-length syncollin transfected INS-1 cells is apparently severed during 
the processing after translation, since the molecular mass of detected proteins in these 
cells was identical to that in the cells transfected with the truncated form lack of the 
domain (Fig. 3.16A). In the course of carrying out this study, the biochemical 
properties of syncollin were further characterized by other laboratories. A series of 
studies on pancreatic acinar cells revealed that the full-length syncollin has a cleavable 
signal sequence and that syncollin can be washed away from granule membranes by 
sodium carbonate (An et al., 2000). The native syncollin appeared to be associated 
with membrane lipid microdomain in zymogen granules and such membrane 
association involves its interaction with cholesterol (Geisse et al., 2002; Hodel et al., 
2001). In addition, syncollin may form a pore structure as homo-oligomers (Geisse et 
al., 2002; Hodel et al., 2001), oligomerization of which may produce a hydrophobic 
region that can render syncollin membrane-associated.  
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4.2.2 N-terminus of syncollin is essential for its sorting to secretory granules 
The presence of the signal peptide-like sequence (N-terminal hydrophobic domain) in 
syncollin during translation indicates that syncollin could be directed to endoplasmic 
reticulum for further process such as forming homo-oligomers. Endogenous syncollin 
in exocrine acinar cells was found to be a secretory granule associated protein 
(Edwardson et al., 1997). In transfected INS-1 β-cell system, the products of 
expression of both syncollin and its truncated form (lacking of N-terminal hydrophobic 
domain) are associated with the membranes. However, immunofluorescence studies 
revealed different intracellular targeting: a co-localization of syncollin staining 
specifically with insulin (indicative of secretory granules) in cells transfected with full-
length syncollin, but not in cells transfected with a truncated form. In the case of the 
latter, expressed syncollin is co-localized mainly with Golgi apparatus and also partly 
with ER. These results suggest that the expressed syncollin in INS-1 cells can be 
sorted to secretory granules as occurred in pancreatic and lacrimal acinar cells 
(Jerdeva, 2003; Tan and Hooi, 2000). However, although truncated syncollin is also 
associated with membranes possibly due to forming a structure with hydrophobic 
property though oligomerization, the targeted location is different from insulin 
granules. It is apparent that the N-terminal hydrophobic domain of syncollin serves as 
the signal peptide in this case and is essential for syncollin sorting to secretory granule 
in both exocrine and endocrine cells. In a study examining the intracellular targeting of 
syncollin by Hodel and Edwardson, it was found that both GFP- and His(6)-tagged (at 
C-terminal) syncollins were sorted to the vesicles in both AtT-20 cells and AR42J cells 
(Hodel et al., 2001). Interestingly, His(6)-tagged syncollin was efficiently targeted to 
secretory granules only in the former but not in latter cells, whereas GFP-tagged 
syncollin was identified in the secretory granules of both types of cells (Hodel et al., 
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2001). In lacrimal acinar cells, syncollin was found mainly in Rab3D-enriched 
secretory vesicles and less in VAMP2- enriched secretory vesicles (Jerdeva, 2003). In 
addition, carbachol stimulation altered the syncollin distribution and syncollin-
associated vesicles were concentrated underneath the plasma membrane (Jerdeva, 
2003). 
4.2.3 Expression of syncollin does not affect insulin content and secretagogue-
evoked [Ca2+]i increases 
Expression of syncollin in INS-1 cells did not alter insulin content, suggesting insulin 
synthesis/processing is not impaired in these cells. Importantly, glucose-induced 
membrane depolarization and [Ca2+]i rises were not affected. [Ca2+]i elevation evoked 
by high K+ (which artificially causes membrane depolarization without generating 
metabolic signaling coupling factors) also remained not reduced. These data indicate 
that the proximal stimulus-secretion coupling signals are not affected by transfection 
of syncollin in INS-1 cells. 
4.2.4  Syncollin on the granules inhibits secretagogue-induced insulin secretion 
Syncollin was originally found as a Ca2+ regulated syntaxin-binding protein capable of 
affecting exocytosis in a cell-free system in an inhibitory manner (Edwardson et al., 
1997). In current study, its possible role in regulated secretion in an exocytosis cell 
system was investigated. The resultant data revealed that syncollin expression in INS-1 
β-cells inhibited stimulated insulin secretion and such inhibitory effect occurred in the 
distal stage of secretion process, since insulin secretion evoked by all stimulants 
including high K+ (presumably a pure Ca2+ stimulation) was impaired. The fact that 
inhibition of stimulated insulin secretion only occurred in the cells transfected with 
full-length syncollin, but not in the cells with the truncated syncollin missing the signal 
 Chapter 4 Discussion  
 - 94 - 
peptide, indicated that syncollin sorting into secretory granules is essential for 
affecting regulated insulin secretion. Transfection of syncollin in rat islets also 
inhibited insulin secretion as reported by other laboratories (Hays, 2002).  
The inhibitory effect of syncollin on stimulated insulin secretion may be related to its 
specific location, its molecular property, and its ability to interact with syntaxin. First, 
inhibition of insulin secretion only occurs in cells in which syncollin is localized in the 
secretory granules, a target partner involved in secretion event. Second, the strong 
membrane association and possible ability to permeabilize the bilayer membrane in the 
form of homo-oligomers make it possible to interact with other granule-associated 
proteins in secretory granules. For instance, syncollin-associated membrane rafts 
contain not only GP-2, a major glycosylphosphatidylinositol (GPI)-anchored 
membrane glycoprotein, which is believed to be a sortase, but also the members of v-
SNAREs such as synaptobrevin-2 (Hansen et al., 1999). Third, syncollin may interact 
with non-granule-associated, or plasmalemma-associated t-SNAREs such as syntaxin 
(Hansen et al., 1999; Tan and Hooi, 2000), since syncollin may be exposed to the 
granule outer surface due to its permeabilizing feature (Geisse et al., 2002). This could 
impede the normal interaction between t- and v-SNAREs as well as SNAREs and 
other regulatory molecules. However, these postulations remain to be verified by 
experimentally. A very recent study expressing of syncollin in AtT-20 neuroendocrine 
cells also displayed similar inhibitory effect on regulated secretion of corticotrophin 
possibly by inducing uncontrolled permeabilization and destabilization of secretory 
granules (Walse et al. 2004). However, it is still unclear whether the interference with 
stimulated secretion by syncollin is resultant of impairment of a step at insulin granule 
recruitment, docking, priming, or fusing.  
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4.2.5 Is there any physiological role of syncollin in insulin secretion in β-cells? 
The physiological function of syncollin is not well defined. Beside existence in 
pancreatic acinar cells, syncollin was also found in small intestine, parotid gland and 
lacrimal acinar cells (Edwardson et al., 1997; Jerdeva, 2003; Tan and Hooi, 2000), and 
its expression was inducible (Tan and Hooi, 2000). All these observation implicate that 
syncollin is a widely expressed protein related to the secretion of digestion enzymes in 
exocrine cells. The sorting of syncollin into zymogens suggests that syncollin may be 
involved in the processing of zymogen contents in exocrine cells. However, the 
syncollin-knockout mice did not display any abnormal phenotype either in zymogen 
contents or in regulated secretion, and only exhibited reduced stress responses 
(Antonin et al., 2002). Nonetheless, its possible physiological role in regulated 
secretion cannot be completely excluded, since a compensatory effect may occur, 
which is observed in many knockout cases. Moreover, syncollin homologue proteins 
may exist in islet β-cells. Indeed, Rhodes et al have identified a syncollin-like protein 
called phosphohipolin in β-cells (Rhodes, 2002). Therefore, it is possible that the 
observed alterations of secretory responses from expressing syncollin in the INS-1 cell 
experimental system are due to either an action of itself or the interference with the 
endogenous homologue. Nevertheless, INS-1 cells expressing syncollin may be used 
as a model cell system to examine its function in the cell. 
In conclusion, the results from this study revealed that insulin secretion induced by 
several well-known secretagogues was inhibited by expression of syncollin in INS-1 β-
cells. The data also indicate that sorting of syncollin to secretory granules is necessary 
to affect the stimulated insulin secretion, an event dictated by the N-terminal 
hydrophobic domain of the protein. There was no alteration of insulin content nor 
impairment in the generation of the proximal signals (membrane depolarization and 
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increase of [Ca2+]i) required for triggering insulin secretion, pointing to an action on 
the distal steps in exocytosis. However, physiological function of syncollin, in 
particular its possible interaction with SNAREs in the intact cell, needs to be further 
clarified.  
 
4.3 Future work  
The results from above work provided evidence for the involvement of Rac1 and 
syncollin in the regulated exocytosis in insulin-secreting INS-1 cells. It is found that 
glucose stimulation could activate Rac1 and this event was essential, but not sufficient, 
for glucose and forskolin stimulated insulin release. The data also suggested that Rac1 
activation might influence the regulated insulin release via an effect on actin 
reorganization which is required for the granule recruitment. However, the effector(s) 
which links the activated Rac1 to the process of actin reorganization and exocytosis is 
still unclear in β-cells. The preliminary results revealed that PIP5K-Iα, an effector of 
Rac1 (Tolias et al., 2000), was translocated from cytosol to the membranes following 
glucose stimulation in INS-1 cells, an event correlated with Rac1 translocation. Thus, 
further work needs to be done on PIP5K-Iα by knocking down this protein (e.g. 
siRNA) to see any change in secretory responses. The other possible effector of Rac1 
worthy of examination is p21-activated kinase (PAK), which mediates actin 
reorganization (Sells et al., 1997) and may participate in other processes. I have 
identified PAK-α, but not PAK-γ, isoform in INS-1 cells. Knock down of PAK may 
improve our understanding how Rac1 activation regulates glucose and forskolin 
stimulated insulin secretion. In addition, the current study by transfection of dominant 
inhibitory Rac1 cannot completely rule out the role of other Rho proteins such as 
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Cdc42 in glucose-induced insulin secretion, since both Rac1 and Cdc42 share and may 
bind to some common GEFs competitively (Feig, 1999). Specifically inactivation or 
knock down of cdc42 may help answer this question. 
Although syncollin might not play a physiological role in regulated insulin secretion in 
β-cells, the latter cell system provides a model to investigate the intracellular targeting 
and interaction of syncollin with other proteins in the cell. This study has found that 
the N-terminal hydrophobic domain is necessary for syncollin sorting into secretory 
granules and expression of syncollin affects the regulated insulin secretion at a distal 
step of exocytosis in INS-1 cells. However, the mechanism underlying inhibition of 
insulin secretion by syncollin is not clear. The possibility of translocation (flip) of this 
protein from the inner of granule membrane to the out surface of granules, where it 
may interact with syntaxin, is required to be explored. Yeast two hybrid system can 
also be useful to screen the interacting proteins of syncollin, especially those involved 
in distal step of exocytosis. In addition, acute knockdown of syncollin by siRNA 
transfection in the cells such as pancreatic acinar cells that express syncollin will help 
understand the possible physiological role of syncollin in exocytosis.  
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The additional data below are not included in the main text of this thesis. 
A1. Expression of dominant inhibitory Rac1 affected cell size and cell 
growth of INS-1 cells 
 
Dominant inhibitory Rac1 transfected cell displayed multiple varieties beside its 
inhibitory effects on stimulated insulin secretion. Detected by flow cytometry, the 
diameter of these cells was smaller than that of control cells (9.9 ± 0.5 vs. 12.6 ± 0.7 
nm) (Fig. 1). No change of cell size was found in constitutively active V12Rac1 
transfected cells. The proliferation rate of N17Rac1 transfected cells was retarded by 
~30% after 6-day culture, and this effect became significant at 2 day culture (Fig. 2). 
The proliferation rate of constitutively active V12Rac1 transfected cells increased 
modestly in comparison with control cells at 6 day culture. Cell cycle analysis by flow 
cytometry displayed an increase in the number of cells arrested in G2/M phases in 
N17Rac1 transfected cells (21.3% vs. 5.8% of total cells); however no apoptosis was 
found in these cells (Fig. 3). Constitutively active Rac1 had no such effects on INS-
cell growth. The decrease of cell size in N17Rac1 transfected cells may result from the 
inhibition of actin polymerization, which is essential for the maintenance of cell 
morphology. G2/M arrest caused by expression of dominant inhibitory N17Rac was 
also found in fibroblasts (Moore et. al., 1997). This effect on cell cycle is probably due 
to interference of Rac1 interaction with its effectors in mitogenic pathway, and may be 
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the reason for cell growth retardation in these cells. These data indicated that 


















Fig. 1. Cells size of INS-1 cells expressing 
Rac1 mutants. INS-1 cells were cultured in 6-
well culture plate before trypsinized and 
resuspended in 1 ml culture medium. Cell size 
was determined by flow cytometry. The cell size 
was indicated as diameter. Data are the mean ± 






































Fig. 2. Proliferation of INS-1 cells expressing Rac1 mutants.  The number of INS-1 cells was 
counted at 0, 2, 4, 6 day after subculture. Data are the mean ± SEM of 3 observations. * P<0.05,  
** P<0.01 vs. control. 
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Fig. 3. Flow cytometric analysis of INS-1 cells expressing Rac1 mutant. INS-1 cell cultured for 
3 days were examined by propidium iodide (PI) staining and flow cytometric analysis. The cells at 
different cell cycle stages were presented as the percentage of total analyzed cells. (Acknowledge 
to Dr. Huo Jianxin for helping to perform the experiment) 
 
 
A2. Both dominant inhibitory and constitutively active Rac1 expression 
reduced F-actin content in INS-1 cells 
 
Although the F-actin staining by rhodamine-phalloidin displayed significant decrease 
in dominant inhibitory Rac1 transfected INS-1 cells, there was only modest signal 
decrease in constitutively active Rac1 transfected cells. To quantify the extent of F-
actin decrement in Rac1 mutant transfected cell, the F-actin content was detected by 
rhodamine-phalloidin staining followed with methanol extraction of the F-actin bound 
dye and rhodamine fluorescence signal was detected by SpectraMax Gemini 
fluorescence plate reader (Molecular Device). The F-actin content was decrease in 
both Rac1 mutant transfected cells. There was 44% decrement of signal in cells 
expressing N17 Rac1 and 39% in cells expressing V12 Rac1 (Fig. 4). The decreased 
signal for F-actin content in cells expressing V12Rac1, although not significant by 
immunofluorescence staining, might be due to the interference caused by V12Rac-
induced activation of actin binding protein confilin and gelsolin that were known 
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regulated by Rac (Stanyon and Bernard, 1999; Azuma et. al., 1998), rather than 
inhibition of action polymerization. Confilin and gelsolin could bind to F-actin and 
block phalloidin binding either by change F-actin structure (McGough et. al.1997) or 
by competitively binding to phalloidin bound position (Allen and Janmey, 1994). The 
results indicated that dominant inhibitory and constitutively active Rac1 interfere with 
F-action polymerization by different mechanisms. 
 
 
Fig. 4. F-actin content in Rac1 mutant 
transfected INS-1 cells. F-actin content was 
assayed by rhodamine-phalloidin staining and 
fluorescence intensity was examined by 
SpectraMax Gemini plate reader. Data are the  
mean ± SEM of 4 observations. * P<0.05, 
** P<0.01 vs. control. 
A3. Glucose stimulation did not induce Rac1 translocation to F-actin 
filaments 
 
To investigate the target of Rac1 translocation induced by glucose stimulation in INS-
1 cells, immunofluorescence staining and confocal microscopy were used to study the 
co-localization of Rac1 and F-actin in these cells. When stimulated by 15 mM glucose, 
no Rac1 and F-actin co-localization was found in the cells in either control cells (Fig. 
5A) or transfected cells (Fig. 5, B and C). The results suggested that glucose 
stimulation could not induce Rac1 translocated to F-actin filaments. The failure of 
Rac1 to co-localize with F-actin filaments spatially may be because Rac1 regulates 
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Fig. 5. (continue to next page) 
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Fig. 5. Glucose stimulation-induced Rac1 translocation did not target to F-actin filaments. 
Rac1 translocation induced by 15 mM glucose stimulation in INS-1 cells was examined by 
immunofluorescence staining with FITC conjugated anti-Rac1 monoclonal antibody. F-actin was 
displayed by rhodamine-phalloidin staining. Control cells (A), N17 transfected cells (B) and 
V12Rac1 transfected cells (C) were examined by Olympus IX70 Fluoroview 300 laser confocal 
microscopy. Bar=10 µm. 
 
 
A4. Glucose- and mastoparan-induced Rac1 translocation to secretory 
granules in INS-1 cells was inhibited by expression of dominant 
inhibitory and constitutively active Rac1. 
 
Both glucose and mastoparan could induce Rac1 translocation to membranes from 
cytosol (Ref. Fig. 3.5, 3.6 and Amin et. al. 2003). To investigate if Rac1 translocation 
targets to secretory granules beside plasma membrane, the Rac1 translocation in INS-1 
cells was detected by immunofluorescence staining and confocal microscopy upon 
stimulated by either glucose or mastoparan. Both 15 mM glucose and 1 µm 
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mastoparan stimulation could induce increment of co-localization of Rac1 and the 
secretory granule marker insulin compared with non-stimulated cells (Fig. 6A). 
However, in cells expressing N17Rac1, there was partly co-localization of Rac1 and 
insulin in non-stimulated cells, and glucose and mastoparan stimulation did not 
augment this co-localization (Fig. 6B). In cells expressing V12Rac1, the signals of co-
localization of Rac1 and insulin was stronger than control cells and N17Rac1 cells 
even in non-stimulated cells, while the glucose and mastoparan stimulation could not 
significantly further increase the extent of co-localization (Fig. 6C). These results 
suggested that both glucose and mastoparan could induce Rac1 translocation to 
secretory granules in INS-1 cells. N17Rac1 and V12Rac1 could localize in secretory 
granules without stimulation. Their location in secretory granules may attenuate or 
abolish endogenous Rac1 translocation induced by secretagogues. 
  Appendix  
 - 125 - 
 













  Appendix  








Fig. 6. Glucose and mastoparan induced Rac1 translocation to secretory granules in INS-1 
cells. Rac1 translocation induced by 15 mM glucose or 1 µM mastoparan stimulation in INS-1 cells 
was examined by immunofluorescence staining with FITC-conjugated anti-Rac1 monoclonal 
antibody. Insulin secretory granules were demonstrated by anti-insulin monoclonal antibody and 
TRITC-conjugated anti-mouse IgG. Control cells (A), N17 transfected cells (B) and V12Rac1 




A5. Syncollin inhibited stimulated insulin secretion in perifused INS-1 cells  
 
The effect of transfection of complete syncollin gene on insulin secretion was also 
examined during perifusion of cells. Stimulation of control cells with 15 mM glucose 
plus 1 µM forskolin for 10 min elicited markedly increase of insulin release while 
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withdrawal of the stimulants caused fast decline of secretory rates (Fig. 7). Two 
additional pulses of stimulation also evoked large insulin secretory peaks. In contrast, 
the stimulated insulin secretion during the three pulses was similarly suppressed in 
syncollin-transfected cells, although the basal secretory rate was not affected (Fig. 7).  
The results suggested that expression of syncollin caused impairment of stimulated 
insulin release may not result from interference with the granule trafficking to a readily 
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Fig. 7. Perfusion assay for insulin secretion in syncollin transfected INS-1 cells. 2 × 106 cells 
were perifused in filter chambers for 30 min with KRB containing 2.8 mM glucose for achieving 
stable basal secretory rates. Thereafter the cells were stimulated with 15 mM glucose plus 1 µM 
forskolin for 3 pulses each of 10 min. Insulin was measured by RIA. The results of insulin 





  Appendix  
 - 128 - 
A6. Forskolin-potentiated insulin release was not totally dependent on 
protein kinase A activation  
 
It is known that activation of protein kinase A (PKA) by cyclic AMP (cAMP) 
potentiates nutrient-induced insulin secretion from islet β-cells. An increase of 
intracellular cAMP levels is achieved by stimulation of adenylyl cyclase following the 
binding of an agonist to its receptor and/or secondary to an elevation of [Ca2+]i. In 
order to understand to what extent the role of PKA in the regulation of insulin 
secretion, a potent and selective PKA inhibitor, N-[2-(p-bromocinnamylamino)ethyl]-
5-isoquinoline sulfonamide (H-89) with a Ki of 0.05 µM for PKA (1/10 of other 
kinases), was applied during 30 min pretreatment and 30 min incubation of insulin-
secreting HIT-T15 cells with stimulants (10 mM glucose alone or plus 1 µM 
forskolin). It is well known that forskolin is able to stimulate adenylyl cyclase directly 
and thus raise cAMP levels in cells. PKA activity in homogenates from cells treated 
with H-89 was suppressed in a dose-dependent manner, as measured by using 
PepTag® Non-Radioactive cAMP-Dependent Protein Kinase Assay Kit (Promega) 
(Fig. 8). Forskolin augmented glucose-induced insulin release by ~3 folds. However, 
0.3 µM H-89 did not inhibit insulin release induced by either 10 mM glucose alone or 
combined with forskolin (Fig. 9). Higher doses of H-89 (1-3 µM) reduced the 
stimulated secretion by ~35% and, under these conditions; forskolin was still capable 
of significantly potentiating the glucose effect (Fig. 9). Ten µM H-89 could abolish 
stimulated insulin release. These results suggested that H-89 might also affect insulin 
secretion via a mode unrelated to PKA inhibition. Therefore, the possible effect of H-
89 on [Ca2+]i was examined by using a fluorescent probe (fura-2). H-89 treatment 
could reduce the [Ca2+]i raises induced by glucose as well as by high (40 mM) K+ 
(reduction by 22, 30, 46, and 85% at 0.3, 1, 3, and 10 M H-89, respectively), and this 
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effect was dose-dependent (Fig. 10). Importantly, this inhibitory effect was acute, as 
demonstrated by the immediate drop of elevated [Ca2+]i due to high K+ after adding the 
agent. In addition, H-89 inhibited K+-evoked insulin release in a dose-dependent 
manner closely correlated to its inhibitory effect on [Ca2+]i. These data indicated that 
H-89 inhibits insulin release mainly by blocking [Ca2+] influx and that an increase of 




































Fig. 8. Protein Kinase A activity under treatment by PKA inhibitor H-89 in HIT-T15 cells. 
PKA activity in cell homogenates was examined by the product of a fluorescence peptide substrate 
catalyzed by PKA. The fluorescence of the product was assayed by Perkin-Elmer LS50B 
luminescence spectrometer. The result of PKA activity was expressed as fluorescence intensity. 
Data are the mean ± SEM of 4 observations.  
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Fig. 9. H-89 inhibited stimulated insulin secretion. HIT-15T cells were 
pretreated with H-89 for 30 min and then incubated with secretagogues for 30 min 
in the continuing presence of H-89. Insulin secretion and insulin content were 
measured by RIA. The values are mean ±SEM of 4 independent experiments in 
triplicates. * P<0.05 and ** P<0.01 vs. control. 
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Fig. 10. Effect of H-89 on high K+ induced [Ca2+]i raises. [Ca2+]i in HIT-15T 
cell suspension was measured by using a fluorescent probe (fura-2). H89 was 
added 2 min before KCl. All traces are representatives of 3 observations in each 
case. The indicated values of KCl additions in the figure denote the final 
concentrations reached in the medium. 
 
 
 
